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Background: There is a lack of systematic understanding of how multimorbidity has been 
constructed and measured. This review aims to examine multimorbidity definition and 
measurement in research. 
Methods: Systematic review registered with PROSPERO (CRD420201724090), with searches 
in nine bibliographic databases, from inception to 21/01/20. Reference lists of retrieved articles 
were hand-searched. Eligible studies measured multimorbidity for any purpose in primary care, 
community or hospital populations. Two reviewers independently reviewed the retrieved 
studies. We used descriptive analyses to understand characteristics and patterns of 
multimorbidity measures.  
Findings: In total, 566 studies were included in this review. 36% of studies did not explicitly 
report how they defined multimorbidity and 13% did not report the conditions their measure 
included. The number of conditions included in measures ranged from 2 to 285 (median 17, 
interquartile range 11-23). 98% of measures included at least one cardiovascular condition, 
compared to at least one metabolic and endocrine (97%), respiratory (93%), musculoskeletal 
(88%) and mental health (79%) condition, whereas chronic infections (27%), haematological 
(24%), ENT (24%), skin (16%) and oral (4%) conditions were uncommonly included. Only 
eight individual conditions were included by more than half of studies (diabetes, stroke, cancer, 
COPD, hypertension, coronary heart disease, chronic kidney disease and heart failure), none 
of which were mental health conditions.  
Interpretation: Measurement of multimorbidity is poorly reported and very variable. 
Consistent reporting of measure definitions should be required by journals, and consensus 
studies are needed to define core and optional conditions to include.  




Research in context 
Evidence before this study 
To identify studies relevant to multimorbidity measurement, we used two key terms 
(multimorbidity AND measurement) to conduct searches in Ovid interface (PsycINFO, 
Embase, Global Health, Medline), Scopus, Web of Science, Cochrane Library, EBSCO 
interface (CINAHL Plus), and ProQuest Dissertations & Theses Global, from inception to 21 
January 2020. Previous narrative systematic reviews examining multimorbidity measure design 
concluded that the number and type of conditions included in multimorbidity counts varies, but 
only include small numbers of studies with incomplete searching. Other reviews examined the 
performance of weighted indices in predicting one or more outcomes, concluding that the 
Charlson Comorbidity Index and Elixhauser’s Comorbidity Index had better predictive 
performance for mortality, the Health-related Quality of Life Comorbidity Index for quality of 
life, Bayliss’s weighted index for physical functioning and self-rated health, and the Adjusted 
Clinical Group System and medication-based indices for healthcare use and costs. However, 
differences in predictive performance between measures (including between weighted indices 
and simple counts of conditions) were small. 
Added value of this study 
This review is larger than any previous review, and systematically examines variation in 
reporting and measurement of multimorbidity. It identifies very considerable variation in how 
multimorbidity is measured in the research literature, particularly in relation to the number and 
nature of conditions included in different studies.  
Implications of all the available evidence 
Multimorbidity research has been growing rapidly over the past decade, but the literature is 
characterised by poor reporting and variation in the number and nature of the conditions 
included in measurement. Reporting would be improved by journals requiring studies to clearly 
report which conditions they included in measurement and why they chose those conditions, 
and codesets or clear definitions of how each individual condition was ascertained. There is a 
need for consensus on defining a core condition set for multimorbidity measurement for all 
studies to report to facilitate comparison across studies, and for guidance on principles for 
defining bespoke condition sets justified by purpose or context. Based on this analysis, we 
recommend a potential core set of conditions to include in all measures, and when other 
conditions should be considered for inclusion. Further consensus studies are needed.    
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Introduction  1 
Due to increasing longevity and better survival from acute conditions, the number of people 2 
living with multiple long term health conditions is rising.1 The UK Academy of Medical 3 
Sciences (2018)2 defines multimorbidity as the co-existence of two or more health conditions 4 
in a population, each one of which should be either a long-term physical non-communicable 5 
disease, a mental health condition of long duration, or a long-term infectious disease. 6 
Multimorbidity differs conceptually from comorbidity where the focus is on any additional 7 
conditions that people with a specified index condition also have.3 There is growing 8 
recognition that existing healthcare systems are seriously challenged by multimorbidity 9 
because they are largely designed to care for patients with single conditions, and research into 10 
multimorbidity is rapidly growing.4,5 11 
Despite the growing research interest in multimorbidity, how it is defined and measured 12 
varies substantially. Several previous studies have examined the definition and measurement 13 
of multimorbidity.6 Although there is agreement that multimorbidity is common and often 14 
burdensome, varying operational definitions of multimorbidity are recognized to have led to 15 
heterogeneous estimates of multimorbidity prevalence and burden.6-9 Operational definitions 16 
differ in terms of the number and types of conditions included, the cut-off point for defining 17 
when multimorbidity is present, whether conditions are simply counted or are weighted in 18 
relation to pre-defined outcomes, and the data sources and data collection methods used.6,8,10-19 
13 There is therefore no clear consensus on how to measure multimorbidity including which 20 
conditions to use in any measure.6,7,14 This makes comparison across research studies difficult 21 
because the underlying measure used by each study can be very different. 22 
The aim of this systematic review was to examine how multimorbidity has been measured in 23 
peer-reviewed studies internationally, including which chronic conditions are included in 24 
measures and how these vary between studies. 25 
Methods 26 
We systematically reviewed studies measuring multimorbidity, and examined the design and 27 
characteristics of multimorbidity measures used. The review protocol was registered with 28 
PROSPERO (CRD42020172409) and Research Registry (reviewregistry839). This paper 29 
reports findings relating to the first two registered objectives. Findings for the third registered 30 
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objective (to identify factors associated with heterogeneity of estimated multimorbidity 31 
prevalence) use different analytical approaches and will be reported separately.   32 
In the review, we followed the CoCoPop framework (Condition, Context and Population) for 33 
systematic review of observational studies to define eligibility criteria and conduct searches.15 34 
The condition set for inclusion in this review is multimorbidity measurement, particularly in 35 
relation to long-term conditions. In terms of context and population, we examined studies 36 
conducted in primary care, community or hospitals where a whole sample of population was 37 
studied. Other inclusion criteria were that studies provided full text and were reported in 38 
English. This review excluded studies that focused on people with a particular condition 39 
(comorbidity) or studied within a specialist service, and studies that were conference 40 
proceeding abstracts, qualitative research or case series.  41 
Search strategy 42 
The search strategy was developed in collaboration with a medical librarian (Supplementary 43 
Table S1). Two sets of key terms (multimorbidity and measure) were combined with Boolean 44 
logic to search for relevant literature. Medical subject headings were used to capture concepts 45 
and maximise the number of studies retrieved. Searches were conducted in Ovid interface 46 
(PsycINFO, Embase, Global Health, Medline), Scopus, Web of Science, Cochrane Library, 47 
EBSCO interface (CINAHL Plus), and ProQuest Dissertations & Theses Global, from 48 
inception to 21/01/20. Following the database searches, we hand-searched reference lists of 49 
retrieved articles and tracked citations. 50 
Study screening and selection 51 
Identified references were exported to EndNote X9 and Excel software for deduplication, and 52 
then imported to Covidence software16 for screening by two independent reviewers of titles, 53 
abstracts, and full-text articles against the eligibility criteria, with disagreement resolved by 54 
discussion and involvement of a third reviewer if necessary.  55 
Data extraction 56 
Data on the characteristics of the included studies were extracted using pre-designed data 57 
extraction tables. The extracted data include 1) authors; 2) year of publication; 3) study title; 58 
4) study purpose; 5) method; 6) country; 7) study participants; 8) sample size; 9) reference 59 
definition of multimorbidity; 10) type of multimorbidity measure (simple counts or weighted 60 
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indices); 11) data collection method/data source (self-report or medical records/administrative 61 
databases); 12) number of conditions included; and 13) the actual conditions included. Due to 62 
the wide variation in labelling of conditions included, we categorised similar conditions into 63 
groups. An example of how we categorised conditions is our category of chronic pain, where 64 
one or more of the underlying studies variously counted ‘neck pain’, ‘back pain’, ‘low back 65 
pain’, ‘chronic low back pain’, ‘pain’, ‘chronic pain’, ‘painful conditions’, ‘trigeminal 66 
neuralgia’ or ‘fibromyalgia’.  67 
Risk of bias assessment 68 
The Effective Public Health Practice Project (EPHPP) quality assessment tool for quantitative 69 
studies was used to assess risk of bias and quality of the included studies.17 The EPHPP tool 70 
evaluates 1) selection bias, 2) study design, 3) confounders, 4) blinding, 5) data collection 71 
method, 6) withdrawals and dropouts. In addition to the six components, we further evaluated 72 
two other types of bias— publication bias and conflict of interest. Each domain was rated as 73 
low, moderate, high, or unclear risk of bias. The overall risk of bias was classified as low, 74 
moderate, or high. We also categorised each study in terms of if they clearly reported the 75 
reference definition for measuring multimorbidity and listed all health conditions included in 76 
the multimorbidity measure. 77 
Data analysis 78 
Descriptive analysis summarised the characteristics of multimorbidity studies and measures. 79 
Categorical data are presented as counts, as percentages, and cross-tabulated with other 80 
categorical data. Pearson’s chi-square test was used to test for statistically significant 81 
differences in cross-tabulated data, and a two-sided p-value of ≤0ꞏ05 was considered 82 
statistically significant. If contingency table expected frequencies were <5, the p-value was 83 
computed for a Monte Carlo test with 2000 duplicates. Post-hoc analysis was performed for 84 
multiple comparisons where there was a statistically significant overall chi-square test. 85 
Relationships between characteristics of multimorbidity measures and the number of 86 
conditions included in the measure were examined using negative binomial generalized linear 87 
regression (the Poisson model was found to be over-dispersed).18 Negative binomial 88 
coefficients were exponentiated to estimate incidence rate ratios (IRR). There was 14% 89 
missingness in the dataset because of incomplete reporting by 73 underlying studies, with 90 
missingness highest for the ‘number of conditions’ count variable (11%), the measure types 91 
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(5%) and data sources (1%) binary variables. For the regression analysis, multiple imputation 92 
with 100 imputed datasets and 20 iterations was performed using Bayesian logistic regression 93 
to impute missing data in binary variables, and negative binomial regression for over-94 
dispersed count data (Y).19, 20 Number of conditions, setting, study population, data source 95 
and the type of measures used in studies were included as covariates in the imputation of 96 
incomplete data. Fraction of missing information (FMI) was computed to quantify loss of 97 
information due to missingness. With the exception of five studies measuring multimorbidity 98 
in children where FMI was 0ꞏ53 (high), FMI ranged from 0ꞏ005-0ꞏ3 (small to moderate) 99 
indicating that multiple imputation uncertainty is acceptable.  100 
The conditions included in different studies were examined in terms of both body systems 101 
with at least one included conditions and individual conditions themselves, and compared 102 
with conditions identified as having the highest burden of Disability Adjusted Life Years the 103 
Global Burden of Disease study 2019.21 All statistical tests were performed using R version 104 
4ꞏ0ꞏ1.22 Where quantitative analyses were not suitable, a narrative overview was undertaken. 105 
Role of funding source 106 
The funder of the study had no role in study design, data collection, data analysis, data 107 
interpretation, writing of the report and the decision to submit this paper. All authors had full 108 
access to all the data in the study and had final responsibility for the decision to submit for 109 
publication. 110 
Results 111 
We identified 13807 articles from databases. Study selection and reasons for exclusion are 112 
summarised in Supplementary Figure S1. Overall, 566 studies were included in this review 113 
(Table 1 and Supplementary Table S3). Most studies were carried out in Europe (n=209, 114 
37%), followed by North America (n=190, 34%), Asia (n=81, 14%) and Australasia (n=42, 115 
7%). There were relatively few studies from South America (n=23, 4%), Africa (n=4, 1%) 116 
and multiple continents (n=17, 3%). The majority of studies were community-based (n=320, 117 
56%) or primary care based (n=126, 22%), with the remainder in hospitals (n=104, 18%), 118 
care homes (n=14, 3%), or multiple settings (n=2, 1%). Data on multimorbidity were 119 
collected through self-report (n=312, 55%), medical records and administrative databases 120 
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(n=240, 43%), or both self-report and medical records/administrative databases (n=6, 1%). 121 
Eight studies (1%) did not report data source. 122 
The most common stated purposes of measuring multimorbidity in the included studies were 123 
examination of its association with various outcomes (n=209, 37%) or associations with risk 124 
factors (n=75, 13%), examination of measure performance (n=117, 21%), identification of 125 
multimorbidity patterns (n=62, 11%), and examination of multimorbidity trajectories over 126 
time (n=19, 3%) (Table 1). Multimorbidity was most commonly examined in studies of all 127 
adults (n=240, 43%), of older adults (n=216, 38%) and of middle-aged and older adults 128 
(n=80, 14%), whereas very few studies measured multimorbidity in children (n=5, 1%) or in 129 
all age groups (n=7, 1%). 130 
Defining multimorbidity. Almost half of the studies defined multimorbidity as the presence of 131 
two or more conditions (n=268, 47%), with smaller numbers using “multiple chronic 132 
conditions” (n=56, 10%), three or more conditions (n=28, 5%) or five or more (n=4, 1%). In 133 
total, 206 (36%) studies did not report any reference definition. Three studies defined severe 134 
or complex multimorbidity (using various terms) in addition to (ordinary) multimorbidity, 135 
with two studies using four or more23,24 and one using five or more25 chronic conditions as a 136 
cut-off point for severe. 137 
Choice of measure type. A simple count of conditions was used to measure multimorbidity in 138 
376 (66%) studies, 155 (27%) studies used weighted indices, 27 (5%) used both types of 139 
measures together, and eight (2%) did not report the type of measure used. Where a weighted 140 
index was used, 149 studies used a disease-based index, and six studies used a medication-141 
based index. The most commonly used disease-based indices were various versions of the 142 
Charlson Comorbidity Index (CCI) (n=64) and the Cumulative Illness Rating Scale-Geriatric 143 
(CIRS-G) (n=25). Medication-based indices included the Chronic Disease Score (n=2),26,27 144 
Rx-Risk (n=2),28,29 the Medication-based Disease Burden Index (MDBI)30 and the Medicine 145 
Comorbidity Index.31 Common weighting methods for indices were: 1) Use of regression 146 
models to calculate weights for each condition based on association with a particular outcome 147 
(e.g. the CCI); 2) Rating of condition severity within each category based on pre-specified 148 
levels of severity (e.g. the CIRS-G32 and Bayliss’s index33); and 3) Assignment of weights 149 
based on existing disease burden literature (e.g. the MDBI30). 150 
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Weighted multimorbidity measures were somewhat more likely to be used in studies 151 
collecting data through medical records/administrative databases (n=118, 54%), whereas 152 
simple counts of conditions were much more commonly used in studies based on self-report 153 
data (n=271, 89%; χ2=57ꞏ00, p=0⸱0004) (Supplementary Table S4). The choice of measures 154 
varied depending on study purpose (χ2=11ꞏ87, p=0ꞏ008), with weighted measures primarily 155 
used to predict outcomes. Similarly, the choice varied by study setting (χ2=153ꞏ60, 156 
p=0ꞏ0004), with simple counts more commonly used in studies in community settings 157 
(n=269, 86%) and primary care (n=81, 74%), whereas weighted measures were 158 
predominantly used in hospital settings (n=73, 78%). 159 
Number of conditions included in measures. Fifty-six (10%) studies did not report how many 160 
conditions were included in their multimorbidity measure, and 41 (7%) compared the 161 
performance of multiple measures in relation to outcomes. For the 469 (83%) studies 162 
examining a single measure, the number of conditions included in the measure ranged from 163 
two to 285 (median 17, interquartile range 11 to 23) (Figure 1). 164 
Associations between study characteristics and the number of conditions included are shown 165 
in Table 2. In univariate analysis, studies measuring multimorbidity in large databases 166 
included more conditions compared to self-report, and community studies included fewer 167 
conditions than those in primary care, hospitals and care homes. Studies that included older 168 
populations included more conditions than those restricted to children or non-older adults. In 169 
the full model, database studies were estimated to include more than twice as many 170 
conditions as self-report studies (IRR 2ꞏ2, 95%CI 1ꞏ8-2ꞏ6). Study setting and study 171 
population were not significantly associated with the number of conditions included in the 172 
measure in the adjusted model. 173 
Choice of conditions included in measures. Seventy-three (13%) studies did not report which 174 
health conditions were included in a measure, and 41 (7%) compared the predictive 175 
performance of multiple measures in relation to outcomes. In the remaining 452 studies, 98% 176 
of measures included at least one cardiovascular condition, followed by including at least one 177 
metabolic and endocrine (97%), respiratory (93%), musculoskeletal (88%) and mental health 178 
(79%) condition (Figure 2). Conversely, chronic infections (27%), haematological (24%), Ear 179 
Nose and Throat (ENT, 24%), skin (16%), oral (4%) and congenital conditions (3%) were 180 
only included by a minority of studies. 181 
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In respect to individual health conditions (Supplementary Figure S2), strikingly, only eight 182 
conditions were included in the multimorbidity measure used in more than half of studies. 183 
Diabetes was included in 91% of studies, with smaller proportions including stroke (79%), 184 
cancer (77%), chronic obstructive pulmonary disease (COPD) (71%), hypertension (70%), 185 
coronary heart disease (61%), chronic renal disease (53%) and heart failure (51%). By 186 
contrast, health conditions included in less than 3% of studies were eating disorder (3%), 187 
aneurysm (3%), malnutrition (3%), fluid and electrolyte disorder (3%), dissociative or 188 
personality disorder (2%), post-traumatic stress disorder (PTSD) (2%), obsessive compulsive 189 
disorder (OCD) (2%), sleep apnoea (1%), chronic fatigue syndrome (1%) and attention 190 
deficit hyperactivity disorder (ADHD) (1%). 191 
No individual mental health condition was included by more than half of studies. 192 
Multimorbidity measures included both physical and mental health conditions in 331 studies 193 
(73%), only physical conditions in 115 studies (25%), and only mental health conditions in 194 
six studies (1%). In studies including both, measures usually only included a small number of 195 
mental health conditions, most commonly depression (49%), dementia (44%) and anxiety 196 
(22%). All other mental health conditions, including schizophrenia, alcohol and drug 197 
dependence and bipolar disorder, were included in less than 20% of studies. 198 
No difference was found in the choice of conditions between studies from low middle-199 
income and high-income countries. Tuberculosis was the only condition where there was 200 
statistically significant variation in inclusion in measures by location. Results from chi-square 201 
post-hoc test indicated that tuberculosis was more commonly included in multimorbidity 202 
measures in Asia (14/68, p=0ꞏ001) compared to Africa (1/3), and Australasia (5/32) Europe 203 
(8/163), North America (5/150) and South America (1/22) (χ2 = 21ꞏ62). 204 
Disease burden and inclusion in measures. Table 3 and Supplementary Figure S3 shows how 205 
often conditions with the highest global burden of Disability Adjusted Life Years (DALYs) 206 
and Years of Life Lost (YLL) 21 were included in multimorbidity measures. Of the top 10 207 
conditions by DALYs burden, coverage in multimorbidity measures ranged from 8 to 91%. 208 
For the top 11 to 25 conditions by DALYs burden, coverage ranged from 4 to 53%. 209 
Conditions in the top 25 of DALYs burden but only included in <30% of multimorbidity 210 
measures were tuberculosis, malnutrition, HIV/AIDS, chronic skin conditions, migraine, ear 211 
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disease, gynaecological disorder, anxiety, oral disorder, consequences of injuries, 212 
osteoarthritis and drug use. 213 
Of the 566 articles measuring multimorbidity, the majority of studies (n=419) were rated to 214 
be of moderate risk of bias, 107 high risk of bias, and 40 low risk of bias (Supplementary 215 
Table S5). There was a statistically significant relationship between the overall risk of bias 216 
evaluated using the EPHPP criteria and the clarity of reporting of multimorbidity 217 
measurement (χ2 =116ꞏ64, p=0ꞏ0004), with studies clearly reporting multimorbidity 218 
measurement being less likely to be at high risk of bias (7% vs 44% of those not clearly 219 
reporting) and more likely to be low risk of bias (9% vs 2%) (Supplementary Table S6).  220 
Discussion 221 
In this review, over a third of studies did not explicitly report their definition of 222 
multimorbidity. Where explicitly reported, the most common definition used was two or more 223 
conditions, with small numbers using three or more, or five or more as cut-offs. One in ten 224 
studies did not state the number or nature of the conditions included in a measure. The 225 
number of conditions included in multimorbidity measures ranged from 2 to 285 (median 17, 226 
interquartile range 11-23). Approximately 66% of studies used a simple count for 227 
multimorbidity measurement (for a range of study purposes), whilst almost 30% of studies 228 
measured multimorbidity using weighted indices (mainly for predicting outcomes).  229 
Studies which reported the conditions included in their multimorbidity measure varied in 230 
which conditions they counted. More than 90% of studies included at least one 231 
cardiovascular, metabolic and endocrine or respiratory condition, but chronic infections, 232 
haematological, ENT, skin, oral and congenital conditions were included by less than one 233 
third of studies. Only eight individual conditions were included in measures used by more 234 
than half of studies, all of which were physical health conditions (diabetes, stroke, 235 
malignancy, hypertension, COPD, coronary heart disease, chronic renal disease and heart 236 
failure).  237 
No mental health condition was included in more than half of studies and a quarter did not 238 
include any mental health condition, which identifies a clear gap in the literature. Mental and 239 
physical multimorbidity has been well recognised to have collective effects on mortality, 240 
quality of life, disability and patient activation.34-36 The inclusion of mental health conditions, 241 
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such as depression, dementia, anxiety disorder, and schizophrenia will usually be required to 242 
properly understand multimorbidity impact.  243 
Previous narrative systematic reviews on multimorbidity measurement focused on the 244 
comparison of how well different weighted indices predict one or more outcomes including 245 
mortality and health care utilisation.10,37-39 Studies were found to commonly use a weighted 246 
index where the purpose is to predict outcomes13,39, and Stirland et al.39 in their recent 247 
systematic review provide recommendations on which weighted index to use for a particular 248 
outcome of interest. Although simple counts with the cut-off of two or more conditions are 249 
commonly used,40 this definition has been criticised as failing to identify people with the 250 
highest needs.41 However, in practice the predictive validity of weighted indices and a simple 251 
count often only differs slightly.42-43 Beyond counting, recent literature has suggested a shift 252 
of focus to better understand the impact of particular disease clusters on clinical outcomes.2,44  253 
We identified that a significant minority of studies did not report how they defined and 254 
measured multimorbidity. At a minimum, we believe that all studies of multimorbidity need 255 
to clearly report: 1) Their core multimorbidity definition, and whether measured by a simple 256 
count or a weighted index; 2) Which conditions are included in the measure; 3) Why these 257 
conditions were selected in relation to the purpose of the study; and 4) How each condition is 258 
defined including any codesets used.  259 
Clear reporting is essential, but our study also found very large variation in the number and 260 
nature of the conditions included in multimorbidity measures. The optimal conditions to 261 
include are likely to vary somewhat by study context and purpose, but we believe there is 262 
value in identifying a core set of conditions which all studies should include, and factors 263 
which might then influence choice of other conditions. We recognise that there is no reason in 264 
principle to exclude any condition from morbidity counts, and that rare diseases are 265 
cumulatively common, but identifying rare conditions in routine data is problematic, and self-266 
report studies are limited by concerns for participant burden and the use of relatively general 267 
condition categories that people choose from.45 Related to this, there is often uncertainty 268 
about when to count condition subgroups separately (eg myocardial infarction, angina) or in 269 
more heterogenous groups (eg coronary artery disease). The 67 conditions we defined based 270 
on the 566 international studies provide insight and along with consideration of conditions 271 
with DALYs or YLL, provide a potential core list to pick from but we recognise that 272 
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researchers may vary from this depending on their purpose. Based on this analysis, Figure 3 273 
suggests a minimal core list of 20 conditions and considerations for choosing other 274 
conditions, but there is a need for consensus studies to refine choices. 275 
The key strengths of this review include comprehensive database searches, assessment of risk 276 
of bias, robust analysis and the systematic examination of multimorbidity measurement in a 277 
large number of studies. Limitations, include that labelling of relevant studies was 278 
inconsistent, meaning that not all relevant studies are likely to have been included, although 279 
this is unlikely to alter the overall conclusion that measurement is poorly reported and highly 280 
variable. There was also considerable variation in how different conditions were named or 281 
grouped by multimorbidity measures, which meant that for synthesis we had to group or 282 
combine some conditions which the underlying studies kept distinct. The likely consequence 283 
is that true heterogeneity of measurement is larger than we observed. 284 
To conclude, this review finds that many studies fail to clearly report how they measured 285 
multimorbidity. Consistent reporting of measure definitions and condition definitions should 286 
be required by journals. Where reported, measurement of multimorbidity is very variable. 287 
There is need for consensus to identify core condition sets that all studies should measure (to 288 
facilitate comparison and synthesis across studies), and study purposes and contexts when 289 
other condition sets will be appropriate.  290 
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Figure titles 309 
Figure 1: Distributions of the number of conditions  310 
Figure 2: Long-term conditions included in multimorbidity measurement (Supplementary Figure S1 311 
shows the 67 conditions in descending order) 312 
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Table 1: Study characteristics (see Supplementary Table S2 for the definition of variables) 















Self-report or interviews 
Medical records and administrative databases 









Only children  
Adults but not older people 
Only middle-aged 
Middle-aged and older 









7   (1%) 
Primary study purpose 
Association of multimorbidity with outcome 
Association of risk factors with multimorbidity  
Patterns or clusters of multimorbidity 
Trajectory of multimorbidity 
Examination of measures 






19   (3%) 
117 (21%) 
  68 (12%) 
  16   (3%) 
Definition of MM/cut-offs 
Not reported 
Two or more chronic conditions 
Three or more chronic conditions 
Five or more chronic conditions 
Multiple chronic conditions 








Type of multimorbidity measure 
Simple counts 
Weighted index of conditions 
Weighted index of medications 



























Table 2: Relationships between the number of conditions included in the multimorbidity measure and other study characteristics 







Data source     
Self-report 16 (11) Ref Ref Ref 
Databases 32 (41) 1ꞏ8 (1ꞏ6-2ꞏ0) 2ꞏ2 (1ꞏ8-2ꞏ6) 0ꞏ12 
Settings     
Community 19 (20) Ref Ref Ref 
Primary care 26 (27) 1ꞏ3 (1ꞏ1-1ꞏ5) 0ꞏ9 (0ꞏ8-1ꞏ1) 0ꞏ11 
Hospitals 27 (34) 1ꞏ5 (1ꞏ2-1ꞏ7) 1ꞏ1 (0ꞏ9-1ꞏ3) 0ꞏ10 
Care homes 43 (77) 2ꞏ3 (1⸱5-3⸱4) 1⸱4 (1⸱0-2⸱2) 0⸱16 
Population     
All adults 25 (32) Ref Ref Ref 
Only children  6   (1) 0⸱3 (0⸱1-0⸱9) 0⸱4 (0⸱1-1⸱1) 0⸱53 
Adults but not older people  12   (4) 0⸱5 (0⸱3-0⸱9) 0⸱6 (0⸱4-1⸱0) 0⸱19 
Only middle-aged 14 (11) 0⸱6 (0⸱3-1⸱2) 0⸱6 (0⸱3-1⸱0) 0⸱30 
Middle-aged and older  24 (40) 0⸱9 (0⸱8-1⸱2) 1⸱0 (0⸱9-1⸱2) 0⸱07 
Only older people 19 (12) 0⸱8 (0⸱7-0⸱9) 0⸱9 (0⸱7-1⸱0) 0⸱11 
Whole population (from birth) 28 (11) 1⸱2 (0⸱7-2⸱0) 1⸱3 (0⸱8-2⸱1) 0⸱09 
Type of measure     
Simple counts 21 (30) Ref Ref Ref 
Weighted measures 25 (17) 1⸱2 (1⸱0-1⸱4) 1⸱7 (1⸱3-2⸱2) 0⸱04 
Interaction     
Weighted measures: Databases   0⸱4 (0⸱3-0⸱5) 0⸱09 
Ref= Reference category. FMI: Fraction of missing information 
Table 3: Conditions with highest global burden of Disability Adjusted Life Years (DALYs) and Years of 
Life Loss (YLL) 




per 100,000 people 
(both sexes combined) 
Attributable age-
standardised Years Life Lost 







Injuries 3,170 1,360          3,390 27% 
Cancer 3,060 2,490          3,520 77% 
Coronary heart disease 2,240 1,580          2,820 61% 
Tuberculosis 2,090 385             692 8% 
Stroke 1,770 1,290          1,840 79% 
COPD 926 499             902 71% 
Diabetes 859 384             452 91% 
Chronic pain 780 Not estimated Not estimated 31% 
Malnutrition 680 151             163 3% 
HIV/AIDS 598 564             533 23% 
Depression 578 Not estimated Not estimated 49% 
Chronic liver disease 560 337             773 49% 
Chronic skin condition 559 29.2            29.1 16% 
Migraine 526 Not estimated Not estimated 16% 
Chronic renal disease 515 350             470 53% 
Ear disease 499 Not estimated Not estimated 22% 
Gynaecological disorder 368 6.75 Not estimated 4% 
Anxiety 360 Not estimated Not estimated 22% 
Dementia 339 254             220 44% 
Oral disorder 285 Not estimated Not estimated 4% 
Vision impairment  278 Not estimated Not estimated 37% 
Asthma 274 140 142 41% 
Heart failure (inc. hypertensive heart disease) 268 239 258 51% 
Osteoarthritis 228 Not estimated Not estimated 18% 
Drug use 225 38.7 106 13% 
Alcohol use 207 20.9 131 16% 
Congenital disease 194 648 747 3% 
Schizophrenia 184 Not estimated Not estimated 17% 
Upper digestive track disease 183 62⸱7 98⸱3 41% 
Anaemia 172 69 70⸱6 17% 
Epilepsy 171 57⸱6 81⸱2 17% 
Valvular disease (inc. rheumatic heart disease) 113 114 101 10% 
Arrhythmia 107 49⸱8 49⸱9 23% 
Bipolar disorder 105 Not estimated Not estimated 6% 
Chronic bowel disease  93 76⸱5 106 20% 
Parkinson’s disease 80 47⸱6 88 23% 
Gall bladder 78 29⸱7 28⸱2 7% 
Learning disability 58 Not estimated Not estimated 6% 
Pancreatic disease 44 24⸱ 59⸱3 6% 
Aneurysm 41 24⸱6 59⸱5 3% 
Connective tissue disease 40 13 7⸱11 35% 
Gout 20 Not estimated Not estimated 9% 
Peripheral arterial disease 20 9⸱85 17⸱2 41% 
Multiple sclerosis 14 9⸱84 7⸱13 8% 
Data on DALYs were derived from the supplementary appendices of Vos et al.21 (Supplementary Figure S3). 
DALYs comprise the estimates of years of life loss due to premature mortality (YLL) and years lived with 
disability (YLD). Vos et al21 report DALYs as a combined burden, but YLL by gender. Conditions relating to 
consequences of injury in this study include paralysis (from causes other than stroke) (17%) and long-term 
musculoskeletal impairment due to injury (10%) 
Potential core conditions with high DALYs 
and/or high YLL
1. Cancer








10. Alcohol and drug misuse
11. Chronic liver disease
12. Chronic renal disease
13. Chronic obstructive pulmonary disease
14. Asthma
15. Sensory impairment (vision or hearing impairment)
16. Musculoskeletal impairment due to injury




Potential considerations for including 
other conditions




Particularly relevant in children
Congenital disease
Learning disability






More detailed condition definition may be relevant 
(e.g. myocardial infarction, stable angina)





















Number of conditions included in multimorbidity measure
25% of studies included < 12 conditions
50% of studies included < 18 conditions





















Conditions grouped by system (N=452)
Cardiovascular (98%) Metabolic and Endocrine (97%)
Respiratory (93%) Musculoskeletal (88%)
Mental health (79%) Cancer (77%)
Neurological (66%) Digestive (65%)
Urogenital (64%) Ophthalmology (37%)
Chronic infection (27%) Haematology (24%)
ENT (24%) Skin (16%)









Supplement to: Ho ISS, Azcoaga-Lorenzo A, Akbari A, et al. Examining variation in the 
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Table S1: Search strategy 
 







1. (multimorbidit$ or multi-morbidit$ or comorbidit$ or co-morbidit$ or 
polymorbidit$ or poly-morbidit$ or multicondition$ or multicondition$ or 
“multiple chronic condition$” or “morbidity burden” or ((multiple or coexisting 
or co-existing or concurrent or con-current or comorbid or co-morbid) adj2 
(disease$ or illness$ or condition$ or diagnos$ or morbid$))).m_titl. 
2. (measure$ or index or indices or instrument$ or scale$ or “disease count$”).mp. 
3. 1 and 2 




1. MM (multimorbidit* or multi-morbidit* or comorbidit* or co-morbidit* or 
polymorbidit* or poly-morbidit* or multicondition* or multicondition* or 
“multiple chronic condition*” or “morbidity burden” or ((multiple or coexisting 
or co-existing or concurrent or con-current or comorbid or co-morbid) N2 
(disease* or illness* or condition* or diagnos* or morbid*)))  
2. AB (measure* or index or indices or instrument* or scale*) 
3. 1 AND 2  
Limiters – Full Text; Human; Language: English  
Scopus TITLE ( multimorbidit* or multi-morbidit* or comorbidit* or co-morbidit* or 
polymorbidit* or poly-morbidit* or multicondition* or multicondition* or “multiple 
chronic condition*” or “morbidity burden” or ( ( multiple or coexisting or co-existing or 
concurrent or con-current or morbid or co-morbid ) W/2 ( disease* or illness* or 
condition* or diagnos?s or morbid* ) ) ) AND TITLE (measure* or index or indices or 
instrument* or scale* or “disease counts”) 
Web of Science (TI=(measure* or index or indices or instrument* or scale*))AND (TI=(multimorbidit* 
or multi-morbidit* or comorbidit* or co-morbidit* or polymorbidit* or poly-morbidit* 
or multicondition* or multicondition* or 'multiple chronic condition*' or 'morbidity 
burden' or ((multiple or coexisting or co-existing or concurrent or con-current or 
comorbid or co-morbid) NEAR/2 (disease* or illness* or condition* or diagnos* or 
morbid*)))) AND LANGUAGE: (English)  
Cochrane library 
 
(multimorbidity or multi-morbidity or comorbidity or co-morbidity or polymorbidity or 
poly-morbidity or multicondition or multicondition or 'multiple chronic conditions' or 
'morbidity burden' or ((multiple or coexisting or co-existing or concurrent or con-current 
or comorbid or co-morbid) NEAR/2 (disease or illness or condition or diagnosis or 
morbid))) AND (measure or index or indices or instrument or scale or “disease 
count*”):ti 
ProQuest Dissertations & Theses 
Global 
ti((multimorbidit* OR multi-morbidit* OR comorbidit* OR co-morbidit* OR 
polymorbidit* OR poly-morbidit* OR multicondition* OR multicondition* OR 'multiple 
chronic condition*' OR 'morbidity burden' OR ((multiple OR coexisting OR co-existing 
OR concurrent OR con-current OR morbid OR co-morbid) NEAR/2 (disease* OR 
illness* OR condition* OR diagnos?s OR morbid*)))) AND noft((measure* OR index 
OR indices OR instrument* OR scale*)) 















Table S2: Definition of variables 
 
Variable name Definition 
Study setting  
Community Studies that used population surveys, insurance claims databases, or research databases 
Primary care Studies that were carried out in primary care settings 
Hospital Studies that were carried out in hospital settings 
Care home Studies that were carried out in care homes, long-term care facilities, or nursing homes 
Data source  
Self-report Studies that collected data using self-report or interviews 
Medical records and administrative 
databases 
Studies that collected data using electronic medical records, medical chart reviews, insurance claims 
databases, pharmacy databases, or research databases 
Study population  
All adults Studies with a sample of population aged 18 and older (n=139), aged 17 and older (n=2), aged 16 and 
older (n=6),  aged 15 and older (n=7), or others (n=86) (e.g. aged 20 and older, aged 21 and older, or 
aged 25 and older)  
Only children Studies with a sample of population aged 18 and younger 
Adults but not older people Studies with a sample of population aged between 18 and 64  
Only middle-aged Studies with a sample of population aged between 45 and 65 (n=3), aged between 40 and 65 (n=2), or 
others (n=3) (e.g. age between 50 and 64, age between 51 and 56, or age between 55 and 65) 
Middle-aged and older 
 
Studies with a sample of population aged 50 and older (n=38), aged 40 and older (n=11), or others 
(n=31) (e.g. aged 52 and older, aged 55 and older, aged 56 and older, or aged 57 and older)  
Only older people Studies with a sample of population aged 65 and older (n=111), aged 60 and older (n=49), or others 




Studies with a sample of all age population 
Primary study purpose  
Association of multimorbidity with 
outcome 
Studies that aimed to examine the association of multimorbidity with one or multiple outcomes 
Association of risk factors with 
multimorbidity 
Studies that aimed to examine the association of risk factors with multimorbidity 
Patterns or clusters of multimorbidity 
 
Studies that aimed to identify patterns or clusters of diseases 
 
Trajectory of multimorbidity Studies that focused on the trends of multimorbidity prevalence or development of multimorbidity over 
time 
Examination of measures Studies that 1) examined the performance of multimorbidity measures (including the development, 
validation or adaptation of a measure) 2) compared the predictive performance for different measures in 
relation to outcomes 3) examined different multimorbidity definitions and how these affected estimates 
of multimorbidity prevalence 4) examined the difference in measure performance between self-report 
and medical records/administrative databases 
Study of people with multimorbidity Studies that focused on multimorbid populations 
Other Studies that merely aimed to estimate the prevalence or burden of multimorbidity (without examining 




Table S3: Study characteristics 
 




  1 Aaby et al. 
(2019)  
2019 Associations of 
MM with 
outcome 




Self-report 19 No 
  2 Aarts et al. 
(2012)  














  3 Aarts et al. 
(2011)  





Europe Community Middle aged and 
older 







  4 Aarts et al. 
(2011) 














  5 Abizanda et 
al. (2014)  
2014 Associations of 
MM with 
outcome 









  6 Agborsangaya 
et al. (2012) 









Self-report 16 Yes 
  7 Agborsangaya 
et al. (2013) 
2013 Associations of 








Self-report 16 Yes 
  8 Agborsangaya 
et al. (2014) 









Self-report 16 Yes 
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  9 Ahrenfeldt et 
al. (2019)  
2019 Associations of 
risk factors with 
MM 
Europe  Europe  Community Middle aged and 
older 




Self-report 10 Yes 
  10 Alimohamma
dian et al. 
(2017) 
2017 Associations of 
risk factors with 
MM 
Iran Asia Community Middle aged and 
older 




Self-report 8 Yes 
  11 Alwhaibi et 
al. (2015) 









Self-report 8 Yes 
  12 Angst et al. 
(2002)  









  13 Appa et al. 
(2014) 









Self-report 16 Yes 








Self-report 12 Yes 
  15 Adams et al. 
(2017) 








Self-report 12 Yes 
  16 Ahmadi et al. 
(2016) 
2016 Associations of 
risk factors with 
MM 
Iran Asia Community Middle aged and 
older 




Self-report 8 Yes 
  17 Ahn et al. 
(2017) 








Self-report 8 Yes 
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  18 Alonso et al. 
(2011) 





























Self-report 19 Yes 
  19 Alonso-Moran 
et al. (2015)  
2015 Associations of 
MM with 
outcome 




Self-report 52 Yes 
  20 Alwhaibi et 
al. (2015) 









Self-report 11 Yes 
  21 Amaral et al. 
(2018) 









Self-report 8 Yes 
  22 An et al. 
(2016) 
2016 Associations of 
risk factors with 
MM 
South Korea Asia Community Middle aged and 
older 




Self-report 8 Yes 
  23 Andersson et 
al.(2018) 









Self-report 10 Yes 
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  24 Andrade et al. 
(2010) 
2010 Patterns of MM Brazil South 
America 




Self-report 23 Yes 
  25 Andrews et al. 
(2001) 
2001 Associations of 
MM with 
outcome 




Self-report 16 Yes 
  26 Araujo et al. 
(2018) 









Self-report 12 Yes 
  27 Adeniji et al. 
(2015)  
2015 Associations of 
MM with 
outcome 




Self-report 5 Yes 
  28 Arnold-Reed 
et al. (2018) 













  29 Arokiasamy et 
al. (2015) 
2015 Associations of 
MM with 
outcome 














Self-report 8 Yes 
  30 Ashworth et 
al. (2019)  
2019 Trajectory of 
MM 









  31 Arfken et al. 
(1998) 
















  32 Assari et al. 
(2015) 






















Self-report 7 Yes 
  33 Assari et al. 
(2019) 





Community Middle aged and 
older 




Self-report 11 Yes 
  34 Aubert et al. 
(2019)  
2019 Patterns of MM Switzerland Europe Hospitals Middle aged and 
older 











  35 Holden et al. 
(2011) 




Self-report 23 Yes 
  36 Violan et al. 
(2013)  
2013 Examination of 
MM measures 









  37 Sinnige et 
al.(2015)  
2015 Patterns of MM The 
Netherlands 
Europe Primary care Middle aged and 
older 









  38 Christofoletti 
et al.(2018) 
2018 Associations of 








Self-report 3 Yes 
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  39 Aubert et al. 
(2019) 
















  40 Aubert et 
al.(2020) 























  41 Cornish et 
al.(2013)  
2013 Associations of 
risk factors with 
MM 
















  42 Zemedikun et 
al.(2018)  









  43 Wensing et al. 
(2001)  









Self-report 25 Yes 
  44 Forjaz et 
al.(2015)  
2015 Associations of 
MM with 
outcome 




Self-report 8 Yes 
  45 Prazeres et 
al.(2016)  
2016 Associations of 
MM with 
outcome 









  46 Mounce et 
al.(2018)  
2018 Associations of 
risk factors with 
MM 
UK Europe Community Middle aged and 
older 




Self-report 15 Yes 
  47 Taylor et 
al.(2010) 
2010 Associations of 
MM with 
outcome 




Self-report 7 Yes 
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  48 Vancampfort 
et al.(2019) 
2019 Associations of 
MM with 
outcome 











Community Middle aged and 
older 




Self-report 11 Yes 
  49 Vancampfort 
et al.(2018) 
2018 Associations of 
risk factors with 
MM 















Self-report 11 Yes 
  50 Aubert et 
al.(2016)  
2016 Associations of 
MM with 
outcome 
Switzerland Europe Primary care Middle aged and 
older 









  51 Autenrieth et 
al.(2013)  
2013 Associations of 
risk factors with 
MM 




Self-report 13 Yes 
  52 Bahat et 
al.(2013) 




Self-report 13 Yes 
  53 Bahat et 
al.(2014) 




Self-report 13 Yes 
  54 Bahler et 
al.(2015)  
2015 Associations of 
MM with 
outcome 















  55 Vancampfort 
et al.(2017) 
2017 Associations of 
MM with 
outcome 










Self-report 11 Yes 
  56 Bahrmann et 
al.(2019)  
2019 Examination of 
MM measures 





  57 Balbale et 
al(2016) 











  58 Banjare et 
al.(2014) 
2014 Associations of 
risk factors with 
MM 




Self-report 20 Yes 
  59 Bao et 
al.(2019) 
2019 Patterns of MM China Asia Community Middle aged and 
older 




Self-report 19 Yes 
  60 Barra et 
al.(2015) 












  61 Bayliss et 
al.(2015) 





Hospitals Only older people 3+ Simple count of 








Self-report 10 Yes 
  62 Bayliss et 
al.(2005) 




Hospitals Only older people NA Simple count of 
diseases, CCI, 
and Rx-risk  
Weighted index Self-report 25 Yes 
  63 Bayliss et 
al.(2009) 




Hospitals Only older people NA Simple count of 
diseases, Quan 
comorbidity 
index, and CDS 
Weighted index Self-report 21 Yes 
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  64 Bekic et 
al.(2019)  
2019 Associations of 
MM with 
outcome 




Self-report 23 Yes 
  65 Beloosesky et 
al.(2011) 
2011 Examination of 
MM measures 



















  66 Bernard et 
al.(2016) 
2016 Associations of 
MM with 
outcome 





  67 Bishop et 
al.(2018) 





Community Middle aged and 
older 




Self-report 8 Yes 
  68 Biswas et 
al.(2019) 




Self-report 3 Yes 
  69 Blakemore et 
al.(2016)  
2016 Associations of 
MM with 
outcome 




Self-report 24 Yes 
  70 Blyth et 
al.(2008) 
2008 Associations of 
MM with 
outcome 













Self-report 18 Yes 
15 
 




  71 Bobo et 
al.(2016) 
2016 Patterns of MM USA North 
America 




Self-report 19 Yes 
  72 Boeckxstaens 
et al.(2015)  
2015 Examination of 
MM measures 












  73 Boeckxstaens 
et al.(2015)  
2015 Examination of 
MM measures 












  74 Booth et 
al.(2014)  
2014 Associations of 
risk factors with 
MM 









  75 Borson et 
al.(2010) 




Community Only older people NA Weighted 
indices (CDS 
and CIRS-G) 
Weighted index Self-report NA NA 
  76 Bottle et 
al.(2011)  
2011 Examination of 
MM measures 

















  77 Bower et 
al.(2013)  
2013 Associations of 
MM with 
outcome 









  78 Bowling et al. 
(2019) 





Community Middle aged and 
older 




Self-report 12 Yes 
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  80 Brenk-Franz 
et al. (2017)  
2017 Study of people 
with MM 
Germany Europe Primary care Middle aged and 
older 










  81 Brett et al. 
(2013) 













  82 Brett et al. 
(2014) 
2014 Associations of 
risk factors with 
MM 













  83 Brilleman et 
al. (2013)  
2013 Examination of 
MM measures 












  84 Britt et al. 
(2008) 













  85 Broeiro-
Goncalves et 
al. (2019)  
2019 Associations of 
risk factors with 
MM 












  86 Bruce et al. 
(2010) 
2010 Associations of 








Self-report 4 Yes 
  87 Buntinx et al. 
(2002)  
2002 Examination of 
MM measures 











  88 Burgers et al. 
(2010) 
















Score=  N + (2* 
self-reported 





Self-report 7 Yes 
  89 Burke et al. 
(2017) 











Self-report 9 Yes 
  90 Buurman et 
al. (2016)  
2016 Patterns of MM The 
Netherlands 












  91 Byers et al. 
(2010) 
2010 Patterns of MM USA North 
America 
Community Middle aged and 
older 




Self-report 2 Yes 
  92 Byles et al. 
(2005) 
2005 Examination of 
MM measures 
Australia Australasia Community Only older people NA Simple counts 







Self-report 25 Yes 
  93 Byles et al. 
(2014) 
2014 Associations of 
MM with 
outcome 
Australia Australasia Community Middle aged and 
older 




Self-report 13 Yes 
  94 Bynum et al. 
(2017) 













  95 Bynum et al. 
(2004) 














  96 Calderon-
Larranaga et 
al. (2018)  
2018 Trajectory of 
MM 




Self-report 60 Yes 
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  97 Calderon-
Larranaga et 
al. (2017)  




Self-report 60 Yes 
  98 Calderon-
Larranaga et 
al. (2019)  
2019 Associations of 
risk factors with 
MM 




Self-report 57 Yes 
  99 Camargo-
Casas et al. 
(2018) 









Self-report 12 Yes 
  100 Canevelli et 
al. (2019)  
2019 Associations of 
MM with 
outcome 









  101 Capisizu et al. 
(2015)  
2015 Study of people 
with MM 
Romania Europe Primary care Middle aged and 
older 









  102 Caracciolo et 
al. (2013)  
2013 Associations of 
MM with 
outcome 









  103 Caramello et 
al. (2019)  
2019 Associations of 
MM with 
outcome 
Italy Europe Hospitals Middle aged and 
older 





  104 Carey et al. 
(2013)  
2013 Examination of 
MM measures 




score based on 
health records 
of conditions ) 











  105 Cesari et al. 
(2006)  
2006 Associations of 
MM with 
outcome 




Self-report 13 Yes 
  106 Chamberlain 
et al. (2020) 
2020 Associations of 








Self-report 21 Yes 
  107 Chan et al. 
(2014) 
2014 Examination of 
MM measures 





  108 Chapleski et 
al. (1997) 





Community Middle aged and 
older 
NA CCI Weighted index Self-report 21 No 
  109 Chaplin et al. 
(2018)  
2018 Study of people 
with MM 




Self-report 11 Yes 
  110 Chapman et 
al. (2015)  
2015 Examination of 
MM measures 
UK Europe Community All adults NA CCI Weighted index Self-report 9 Yes 
  111 Charlson et al. 
(2007) 










  112 Charlson et al. 
(2008) 









  113 Charlson et al. 
(1987) 















  114 Charlson et al. 
(2014) 









  115 Chaudhry et 
al. (2005) 









  116 Chen et al. 
(2018) 
2018 Associations of 
MM with 
outcome 









  117 Chen et al. 
(2018) 
2018 Associations of 
MM with 
outcome 
China Asia Community Middle aged and 
older 




Self-report 16 Yes 
  118 Chen et al. 
(2011) 









Self-report 8 Yes 
  119 Cheung et al. 
(2013) 
2013 Associations of 
MM with 
outcome 
Hong Kong Asia Community Middle aged and 
older 




Self-report 18 Yes 
  120 Chin et al. 
(2019) 
2019 Study of people 
with MM 




Self-report 20 Yes 
  121 Chong et al. 
(2012) 




Self-report 13 Yes 
  122 Chow et al. 
(2014) 
2014 Study of people 
with MM 















  123 Chu et al. 
(2018) 
2018 Associations of 
MM with 
outcome 
Hong Kong Asia Primary care Middle aged and 
older 













  124 Chudasama et 
al. (2019)  
2019 Associations of 
MM with 
outcome 
UK Europe Community Middle aged and 
older 









  125 Cimarras-Otal 
et al. (2014)  
2014 Associations of 
risk factors with 
MM 




Self-report 20 Yes 
  126 Clerencia-
Sierra et al. 
(2015)  







  127 Chen et al. 
(2014) 
2014 Associations of 
MM with 
outcome 





  128 Chen et al. 
(2019) 
2019 Associations of 
MM with 
outcome 





  129 Chen et al. 
(2010) 
2010 Associations of 
MM with 
outcome 





  130 Cheng et al. 
(2020) 
2020 Study of people 
with MM 











  131 Chin et al. 
(2016) 
2016 Associations of 
MM with 
outcome 




Self-report 8 Yes 
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  132 Clark et al. 
(2018) 









  133 Collins et al. 
(2018) 









Self-report 9 Yes 
  134 Contant et al. 
(2019) 













  135 Corrao et al. 
(2017)  
2017 Examination of 
MM measures 









  136 Formiga et al. 
(2016)  
2016 Associations of 
MM with 
outcome 
Spain Europe Community Only older people NA CCI Weighted index Self-report 19 Yes 
  137 Fortin et al. 
(2006) 










  138 Agrawal et al. 
(2016) 
2016 Associations of 













Self-report 9 Yes 
  139 Fortin et al. 
(2007) 
2007 Patterns of MM Canada North 
America 





  140 Gorup et al. 
(2017)  
2017 Associations of 
MM with 
outcome 











  141 Griffith et al. 
(2018)  
2018 Associations of 
MM with 
outcome 





Self-report 18 Yes 
  142 Gu et al. 
(2018) 
2018 Associations of 
MM with 
outcome 




Self-report 13 Yes 
  143 Guido et al. 
(2014)  
2014 Associations of 
MM with 
outcome 





  144 Gunn et al. 
(2012) 
2012 Associations of 
MM with 
outcome 




Self-report 12 Yes 
  145 Han et al. 
(2013) 














  146 Hanlon et al. 
(2018)  









  147 Incalzi et al. 
(1997)  
1997 Associations of 
MM with 
outcome 










  148 Jansa et al. 
(2010)  
2010 Associations of 
MM with 
outcome 




Self-report 6 Yes 
  149 Jantsch et al. 
(2018) 
2018 Associations of 




Community All adults but not 
older people 




Self-report 11 Yes 
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  150 John et al. 
(2003) 
2003 Patterns of MM USA North 
America 




Self-report 11 Yes 
  151 Johnson-
Lawrence et 
al. (2017) 
2017 Associations of 




Community All adults but not 
older people 




Self-report 9 Yes 
  152 Johnston et al. 
(2019)  
2019 Associations of 
risk factors with 
MM 
UK Europe Community All adults but not 
older people 







  153 Jones et al. 
(2016) 








Self-report 10 Yes 
  154 Jovic et al. 
(2016)  
2016 Associations of 
risk factors with 
MM 




Self-report 13 Yes 
  155 Jovic et al. 
(2016)  




Self-report 13 Yes 
  156 Juul-Larsen et 
al. (2020)  




Self-report 34 Yes 
  157 Hudon et al. 
(2008) 
2008 Associations of 








Self-report 25 Yes 
  158 Hussain et al. 
(2015) 
2015 Patterns of MM Indonesia Asia Community Middle aged and 
older 




Self-report 12 Yes 
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  159 Hussin et al. 
(2019) 
2019 Associations of 
risk factors with 
MM 
Malaysia Asia Community Middle aged and 
older 




Self-report 15 Yes 
  160 Hutchinson et 
al. (2015) 
2015 Associations of 
MM with 
outcome 





  161 Ie et al. (2017) 2017 Patterns of MM USA North 
America 









  162 Ishizaki et al. 
(2019) 
2019 Associations of 
MM with 
outcome 




Self-report 9 Yes 
  163 Jackson et al. 
(2015) 
2015 Trajectory of 
MM 




Self-report 18 Yes 
  164 Jacobi et al. 
(2004)  




Self-report 6 Yes 
  165 Januel et al. 
(2011)  
2011 Examination of 
MM measures 









  166 Danon-Hersch 
et al. (2012)  
2012 Associations of 
MM with 
outcome 




Self-report 12 Yes 
  167 de Heer et al. 
(2013) 
2013 Associations of 








Self-report 19 Yes 
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  168 de Souto 
Barreto et al. 
(2014)  
2014 Associations of 
MM with 
outcome 




Self-report 11 Yes 
  169 Demirchyan 
et al. (2013) 
2013 Associations of 
risk factors with 
MM 







  170 Fabbri et al. 
(2015)  
2015 Associations of 
risk factors with 
MM 




Self-report 15 Yes 
  171 Fabbri et al. 
(2016) 









Self-report 13 Yes 
  172 Farley et al. 
(2006) 




Hospitals All adults NA CCI, 
Elixhauser, 
RxRisk 





  173 Feng et al. 
(2018) 





Community All adults but not 
older people 









  174 Fergusson et 
al. (1993) 




Self-report 5 Yes 
  175 Ferreira 
Agreli et al 
(2017) 









Self-report 25 Yes 
  176 Fillenbaum et 
al. (2000) 









Self-report 5 Yes 
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  177 Finney Rutten 
et al. (2016) 









Self-report 6 Yes 
  178 Ford et al. 
(2019)  
2019 Study of people 
with MM 







  179 Kadam et al. 
(2007)  
2007 Associations of 
MM with 
outcome 
UK Europe Primary care Middle aged and 
older 









  180 Kaneko et al. 
(2019) 
2019 Associations of 
risk factors with 
MM 







  181 Kang et al. 
(2017) 
2017 Associations of 
risk factors with 
MM 
South Korea Asia Primary care All adults but not 
older people 









  182 Gruneir et al. 
(2016) 














  183 Gandhi et al. 
(2020) 









Self-report 8 Yes 
  184 Corrao et al. 
(2019)  





  185 Corrao et 
al.(2020)  
2020 Examination of 
MM measures 











  186 Cortaredona 
et al.(2017)  
2017 Examination of 
MM measures 
France Europe Community All adults Index 
score 





  187 Costa et al. 
(2018) 
2018 Patterns of MM Brazil South 
America 




Self-report 29 Yes 
  188 Cramm et al. 
(2018)  















  189 Crooks et al. 
(2016)  
2016 Examination of 
MM measures 
UK Europe Primary care 
and hospitals 
All adults NA Elixhauser, 
CCI, linked 
score (read code 
and ICD-10) 







  190 Crooks et al. 
(2015)  
2015 Examination of 
MM measures 
UK Europe Primary care 
and hospitals 





  191 Dankel et al. 
(2018) 
2018 Associations of 








Self-report 13 Yes 
  192 Dankel et al. 
(2017) 









Self-report 14 Yes 
  193 Dattalo et al. 
(2017) 













and the Johns 
Hopkins ACG® 













  194 de Carvalho et 
al. (2018) 
2018 Patterns of MM Brazil South 
America 




Self-report 14 Yes 
  195 de Souza Leal 
Neto et 
al.(2016) 
2016 Associations of 








Self-report 11 Yes 
  196 Verghese et 
al. (2016) 












  197 Der-
Martirosian et 
al. (2013) 





Community Only older people NA Seattle Index of 
Comorbidity 
Weighted index Self-report 7 Yes 
  198 Rizzuto et al. 
(2017)  
2017 Associations of 
MM with 
outcome 




Self-report 36 Yes 
  199 Rivera-
Almaraz et al. 
(2018) 
2018 Patterns of MM Mexico South 
America 
Community Middle aged and 
older 




Self-report 9 Yes 
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  200 Schneider et 
al. (2012)  
2012 Examination of 
MM measures 





  201 Schneeweiss 
et al. (2004) 










Romano's CCI  





  202 Sara et 
al.(2018) 
2018 Other Bangladesh Asia Hospitals Only older people 2+ CIRS-G Weighted index Self-report 14 Yes 
  203 Dhalwani et 
al. (2017)  
2017 Associations of 
risk factors with 
MM 
UK Europe Community Middle aged and 
older 




Self-report 18 Yes 
  204 Di Bari et al. 
(2006)  
2006 Examination of 
MM measures 










Self-report NA NA 
  205 Dias et al. 
(2015)  
2015 Examination of 
MM measures 


















  206 DiBonaventur
a et al. (2018) 
[103] 
2018 Associations of 




Europe Community All adults NA CCI Weighted index Self-report 19 Yes 
  207 Diederichs et 
al.(2012)  
2012 Associations of 
MM with 
outcome 




Self-report 10 Yes 
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  208 Diez-
Manglano et 
al.(2015)  
2015 Associations of 
MM with 
outcome 







Self-report 15 Yes 
  209 Dong et al. 
(2013) 
2013 Examination of 
MM measures 











  210 Donze et 
al.(2013) 









Self-report 13 Yes 
  211 Drewes et 
al.(2011)  








Self-report 9 Yes 
  212 Droomers et 
al. (2004)  
2004 Other The 
Netherlands 




Self-report 24 No 
  213 Eakin et al. 
(2007) 








Self-report 14 Yes 
  214 Sangha et al. 
(2003) 











Weighted index Self-report 13 Yes 
  215 Salman et al. 
(2019)  
2019 Study of people 
with MM 




Self-report 10 Yes 
  216 Salisbury et 
al. (2018)  
2018 Study of people 
with MM 















  217 Rius et al. 
(2008)  
2008 Examination of 
MM measures 





Weighted index Self-report 16 Yes 
  218 Elixhauser et 
al. (1998) 




Hospitals All adults NA Elixhauser's 
Comorbidity 
Index 





  219 Eton et al. 
(2017) 











  220 Fabbri et al. 
(2015) 
2015 Associations of 








Self-report 15 Yes 
  221 Feng et al. 
(2018) 














  222 Ferrer et al. 
(2017)  












  223 Ferro et al. 
(2019) 












  224 Foguet-Boreu 
et al. (2015)  
2015 Study of people 
with MM 











  225 Fortin et 
al.(2006) 























  226 Fortin et 
al.(2005) 
2005 Other Canada North 
America 












  227 Fortin et 
al.(2014) 
2014 Associations of 




Community Middle aged and 
older 




Self-report 14 Yes 
  228 Fortin et al. 
(2005) 




















  229 Fortin et al. 
(2010) 












  230 Fortin et al. 
(2017) 













  231 Fraccaro et al. 
(2016)  
2016 Trajectory of 
MM 





  232 Fuchs et al. 
(1998) 
1998 Associations of 
MM with 
outcome 




Self-report 14 Yes 
  233 Fung et al. 
(2008) 









Self-report 16 Yes 
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  234 Gadermann et 
al. (2012)  




Self-report 19 Yes 
  235 Gagne et al. 
(2011) 















  236 Galenkamp et 
al. (2011)  





Europe Community Middle aged and 
older 




Self-report 7 Yes 
  237 Galenkamp et 
al. (2016)  












Self-report 8 Yes 
  238 Gallegos-
Carrillo et 
al.(2009) 








Self-report 10 Yes 
  239 Gallo et 
al.(2016) 




Community Only older people NA CCI Weighted index Self-report 19 Yes 
  240 Gamma et al. 
(2001)  
2001 Associations of 
MM with 
outcome 
Switzerland Europe Community All adults but not 
older people 




Self-report 14 Yes 
  241 Gaulin et 
al.(2019) 























  242 Gawron et 
al.(2020) 





Hospitals All adults but not 
older people 











  243 Ge et al. 
(2018) 
2018 Associations of 
MM with 
outcome 




Self-report 17 Yes 
  244 Ge et al. 
(2019) 
2019 Associations of 
MM with 
outcome 




Self-report 17 Yes 
  245 Gibbons et al. 
(2013)  
2013 Study of people 
with MM 














  246 Gili et al. 
(2010)  
2010 Associations of 
MM with 
outcome 











  247 Gnadinger et 
al. (2018)  
2018 Other Switzerland Europe Primary care All adults 3+ Thurgau 
Morbidity Index 







  248 Excoffier et 
al.(2018)  









  249 Turner Goins 
et al.(2019) 
2019 Associations of 




Community Middle aged and 
older 
NA Goins's index Simple counts 
of diseases 
Self-report 32 Yes 
  250 Gould et 
al.(2016) 









Self-report 7 Yes 
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  251 Griffith et 
al.(2019) 




Community Middle aged and 
older 




Self-report 31 Yes 
  252 Habib et 
al.(2014) 
2014 Associations of 
risk factors with 
MM 







  253 Harris et 
al.(2016) 
















  254 Harrison et 
al.(2017) 









  255 Harrison et 
al.(2012)  
2012 Study of people 
with MM 




Self-report 23 No 
  256 Hayek et 
al.(2017) 




Self-report 10 Yes 
  257 Heller et 
al.(2009) 





Community Only older people NA Deyo CCI Weighted index Self-report 23 Yes 
  258 Helvik et 
al.(2013)  
2013 Associations of 
MM with 
outcome 
Norway Europe Hospitals Only older people NA Quan's CCI 
(2005) 





  259 Henninger et 
al.(2012) 









Self-report 9 Yes 
37 
 




  260 Hernandez et 
al.(2019)  
2019 Patterns of MM Ireland Europe Community Middle aged and 
older 




Self-report 31 Yes 
  261 Hillen et 
al.(2017) 











  262 Ho et 
al.(2014) 
2014 Associations of 
MM with 
outcome 
Singapore Asia Community Middle aged and 
older 




Self-report 12 Yes 
  263 Holman et 
al.(2005) 
2005 Examination of 
MM measures 





Scoring System  





  264 Hopman et 
al.(2016)  















  265 Hu et 
al.(2019) 









  266 Huang et 
al.(2019) 













  267 Hudon et 
al.(2012) 





Primary care All adults 2+ Disease Burden 
Morbidity 
Assessment  
Weighted index Self-report 11 Yes 
  268 Katikireddi et 
al.(2017)  
2017 Associations of 
risk factors with 
MM 




Self-report 40 Yes 
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  269 Kenning et 
al.(2015)  
2015 Study of people 
with MM 




Self-report 21 Yes 
  270 Khan et 
al.(2010)  
2010 Examination of 
MM measures 
UK Europe Primary care Middle aged and 
older 





  271 Khan et 
al.(2019) 
2019 Associations of 
risk factors with 
MM 




Self-report 6 Yes 
  272 Ki et al. 
(2017) 
2017 Associations of 
risk factors with 
MM 









  273 Kil et al. 
(2012) 
2012 Examination of 
MM measures 










  274 Kilgore et al. 
(2012) 









  275 Kiliari et al. 
(2013)  







  276 Kim et al. 
(2012) 
2012 Associations of 
MM with 
outcome 




Self-report 14 Yes 
  277 Kim et al. 
(2018) 
2018 Associations of 
MM with 
outcome 




Self-report 34 Yes 
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  278 Kim et al. 
(2018)  
2018 Associations of 
MM with 
outcome 
Ireland Europe Primary care Middle aged and 
older 
MCC RxRisk-V Weighted index Self-report 27 Yes 
  279 King et 
al.(2018) 








Self-report 11 Yes 
  280 Kingston et al. 
(2018)  
2018 Trajectory of 
MM 




Self-report 12 Yes 
  281 Koyanagi et 
al.(2018) 










Community Middle aged and 
older 




Self-report 10 Yes 
  282 Kriegsman et 
al. (2004)  





Europe Community Middle aged and 
older 




Self-report 7 Yes 
  283 Kristensen et 
al. (2019)  
2019 Associations of 
MM with 
outcome 
Germany Europe Community Middle aged and 
older 




Self-report 13 Yes 
  284 Kristensen et 
al. (2019)  
2019 Associations of 
MM with 
outcome 
Germany Europe Community Middle aged and 
older 




Self-report 13 Yes 
  285 Kumar et al. 
(2016) 













  286 Kunna et al. 
(2017) 
2017 Study of people 
with MM 
China, Ghana Multiple 
continents 
Community Middle aged and 
older 




Self-report 7 Yes 
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  287 Kusumastuti 
et al. (2017) 





Community Middle aged and 
older 




Self-report 7 Yes 
  288 Kuwornu et 
al. (2014) 
2014 Patterns of MM Canada North 
America 




Self-report 15 Yes 
  289 Lai et al. 
(2019) 
2019 Associations of 
risk factors with 
MM 




Self-report 14 Yes 
  290 Lai et al. 
(2018) 
2018 Associations of 
MM with 
outcome 




Self-report 11 Yes 
  291 Laires et al. 
(2019)  
2019 Associations of 
MM with 
outcome 




Self-report 13 Yes 
  292 Landi et al. 
(2016)  
2016 Associations of 
MM with 
outcome 




Self-report 13 Yes 
  293 Landi et al. 
(2010) 
2010 Associations of 
MM with 
outcome 




Self-report 13 Yes 
  294 Lang et al. 
(2015) 









Self-report 6 Yes 
  295 Langsted et al. 
(2020)  
2020 Associations of 
MM with 
outcome 











  296 Laux et al. 
(2008)  
2008 Associations of 
MM with 
outcome 











  297 Lawson et al. 
(2013)  
2013 Associations of 
MM with 
outcome 









  298 Le Cossec et 
al. (2016)  
2016 Associations of 
risk factors with 
MM 
France Europe Community Middle aged and 
older 




Self-report 4 Yes 
  299 Lee et al. 
(2020) 
2020 Study of people 
with MM 







  300 Lee et al. 
(2016) 




Primary care Only older people 2+ CCI Weighted index Self-report 19 Yes 
  301 Lee et al. 
(2007) 
2007 Patterns of MM USA North 
America 









  302 Lee et al. 
(2018) 
2018 Associations of 
MM with 
outcome 











  303 Lenzi et al. 
(2016)  
2016 Associations of 
risk factors with 
MM 









  304 LePage et al. 
(2014) 
















  305 Li et al. 
(2016)  
2016 Associations of 
MM with 
outcome 




Self-report 12 Yes 
  306 Li et al. 
(2019) 




Community Middle aged and 
older 




Self-report 8 Yes 
  307 Librero et al. 
(1999)  
1999 Associations of 
MM with 
outcome 





  308 Liu-Ambrose 
et al. (2010) 











  309 Lobo-Escolar 
et al. (2008)  
2008 Associations of 
MM with 
outcome 
Spain Europe Community Middle aged and 
older 




Self-report 12 Yes 
  310 Loprinzi 
(2015) 
2015 Associations of 








Self-report 14 Yes 
  311 Loprinzi 
(2017) 
2017 Associations of 








Self-report 14 Yes 
  312 Lorem et al. 
(2016)  
2016 Examination of 
MM measures 
Norway Europe Community All adults NA CCI and health 
impact index 
Weighted index Self-report 28 Yes 
  313 Low et al. 
(2019) 
2019 Associations of 
risk factors with 
MM 




Self-report 48 Yes 
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  314 Lu et al. 
(2011) 
2011 Examination of 
MM measures 
Australia Australasia Hospitals Only older people NA CCI and Rx-
Risk 





  315 Lujic et al. 
(2017) 
2017 Examination of 
MM measures 
Australia Australasia Community Middle aged and 
older 




Self-report 8 Yes 
  316 Lupianez-
Villanueva et 
al.(2018)  









Self-report 13 Yes 
  317 Zhou et al. 
(2018) 










Self-report 9 Yes 
  318 Zhang et al. 
(2019) 




Self-report 11 Yes 
  319 Yamada et al. 
(2015) [148] 





Europe Care homes Middle aged and 
older 





  320 Wong et al. 
(2010) 









Self-report 7 Yes 













  322 Weimann et 
al. (2016) 
2016 Trajectory of 
MM 




Self-report 4 Yes 
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  323 Wei et al. 
(2019) 





Community All adults NA Multimorbidity 
weighted index 
Weighted index Self-report 81 Yes 
  324 Wang et al. 
(2017) 
2017 Examination of 
MM measures 




Self-report 8 Yes 
  325 Wang et al. 
(2017) 





Hospitals All adults NA Elixhauser's 
Comorbidity 
Index 





  326 Wang et al. 
(2007) 
2007 Associations of 
MM with 
outcome 





  327 Wang et al. 
(2019) 
2019 Associations of 
MM with 
outcome 




Self-report 5 Yes 
  328 Walker et al. 
(2007) 
2007 Associations of 
MM with 
outcome 




Self-report 7 Yes 
  329 Wade et al. 
(2019) 
2019 Associations of 
MM with 
outcome 




Self-report 12 Yes 
  330 Maciejewski 
et al. (2019) 














  331 MacKnight et 
al. (2001) 
2001 Associations of 















  332 Marengoni et 
al. (2016)  
2016 Patterns of MM Sweden Europe Community Only older people 2+ CIRS-G Weighted index Self-report 14 Yes 
  333 Marengoni et 
al. (2009)  




Self-report 15 Yes 
  334 Déruaz-Luyet 
et al. (2017)  









  335 Marengoni et 
al. (2009)  
2009 Associations of 
MM with 
outcome 




Self-report 22 Yes 
  336 Marques et al. 
(2018)  
2018 Associations of 








Self-report 6 Yes 
  337 Martin-Garcia 
et al. (2013)  
2013 Associations of 
MM with 
outcome 





  338 Martinez-
Velilla et al. 
(2014)  
2014 Examination of 
MM measures 
















  339 Mavaddat et 
al. (2014)  
2014 Associations of 
MM with 
outcome 
UK Europe Primary care Middle aged and 
older 




Self-report 6 Yes 
  340 Mazzella et al. 
(2010)   
2010 Associations of 
MM with 
outcome 











  341 McDaid et al. 
(2013)  
2013 Associations of 
MM with 
outcome 
Ireland Europe Community Middle aged and 
older 




Self-report 8 Yes 
  342 Md Yusof et 
al. (2010)  
2010 Examination of 
MM measures 




Weighted index Self-report NA NA 
  343 Melis et al. 
(2014)  
2014 Trajectory of 
MM 









  344 Mercer et al. 
(2016) [161] 
2016 Study of people 
with MM 











  345 Min et al. 
(2007) 









Self-report 9 Yes 
  346 Min et al. 
(2014) 














  347 Mnatzaganian 
et al. (2012) 
2012 Examination of 
MM measures 











  348 Mokraoui et 
al. (2016) 








Self-report 21 Yes 
  349 Momtaz et al. 
(2010) 
2010 Associations of 
MM with 
outcome 




Self-report 16 Yes 
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  350 Mondor et al. 
(2018) 













  351 Mondor et al. 
(2016) 














  352 Montes et al. 
(2020) 









Self-report 28 Yes 
  353 Moore et al. 
(2014) 
2014 Patterns of MM USA North 
America 









  354 Mori et al. 
(2019) 
2019 Associations of 
MM with 
outcome 





  355 Mortsiefer et 
al (2017) 
[162] 
2017 Study of people 
with MM 
Germany Europe Community Only older people NA Unclear Unclear NA Uncl
ear 
No 
  356 Mueller-
Schotte et al. 
(2020)  









Self-report 17 Yes 
  357 Muggah et al. 
(2012) 














  358 Mukherjee et 
al. (2011) 




















  359 Nagel et al. 
(2017)  
2017 Associations of 
MM with 
outcome 




Self-report 21 Yes 
  360 Nagel et al. 
(2008) 
2008 Associations of 
risk factors with 
MM 
Germany Europe Community Middle aged and 
older 




Self-report 15 Yes 
  361 Nagl et al. 
(2012) 
2012 Associations of 
MM with 
outcome 
Germany Europe Primary care Only older people 2+ Cumulative 
multimorbidity 









  362 Naithani et al. 
(2010)  
2010 Associations of 
MM with 
outcome 





  363 Narayan et al. 
(2017) 
2017 Examination of 
MM measures 
New Zealand Australasia Community Only older people NA Medicines 
Comorbidity 
Index  





  364 New et al. 
(2017) 
2017 Examination of 
MM measures 
Australia Australasia Hospitals All adults NA CCI and CIRS-
G 





  365 Nguyen et al. 
(2019) 
2019 Associations of 








Self-report 19 Yes 
  366 Niedzwiedz et 
al. (2019) 
2019 Associations of 




Community Middle aged and 
older 




Self-report 8 Yes 
  367 Nilssen et al. 
(2014)  
2014 Examination of 
MM measures 















  368 Nobrega et al. 
(2009) 










  369 Nunes et al. 
(2016) 
2016 Patterns of MM Brazil South 
America 




Self-report 11 Yes 
  370 Nunes et al. 
(2017) 
2017 Associations of 








Self-report 22 Yes 
  371 Nunes et 
al.(2015) 
2015 Other Brazil South 
America 




Self-report 17 Yes 
  372 Nutzel  et 
al.(2014)  









  373 Olaya  et 
al.(2017)  
2017 Associations of 
MM with 
outcome 




Self-report 7 Yes 
  374 Olaya  et 
al.(2017)  
2017 Patterns of MM Spain Europe Community Middle aged and 
older 




Self-report 11 Yes 
  375 Olivares  et 
al.(2017) 
2017 Associations of 











  376 Olsson et 
al.(2005)  
2005 Associations of 
MM with 
outcome 











  377 Ou et 
al.(2016) 




Community All adults NA Refined 
HRQoL-CI 





  378 Pache et 
al.(2015)  
2015 Examination of 
MM measures 




Self-report 38 Yes 
  379 Paddison et 
al.(2015)  
2015 Study of people 
with MM 









  380 Park et al. 
(2018) 
2018 Associations of 
MM with 
outcome 
South Korea Asia Community Middle aged and 
older 




Self-report 25 Yes 
  381 Park et al. 
(2014) 
2014 Study of people 
with MM 
South Korea Asia Care homes Middle aged and 
older 
2+ Unclear Unclear NA Uncl
ear 
No 
  382 Parker et 
al.(2003) 




Hospitals All adults NA CDS and Deyo 
CCI 





  383 Parkerson et 
al.(1993) 




Primary care All adults NA Duke Severity 
of Illness 
Checklist  





  384 Patel et 
al.(2006) 





Community Middle aged and 
older 




Self-report 5 Yes 
  385 Pati et 
al.(2016) 
2016 Examination of 
MM measures 





Weighted index Self-report 18 Yes 
51 
 




  386 Pati et 
al.(2019) 
2019 Associations of 
MM with 
outcome 







Self-report 21 Yes 
  387 Pati et 
al.(2017) 







Self-report 21 Yes 
  388 Patrick et 
al.(2001) 










  389 Payne et 
al.(2013)  
2013 Associations of 
MM with 
outcome 









  390 Peng et 
al.(2014) 
2014 Associations of 
MM with 
outcome 
Taiwan Asia Hospitals Only older people NA CCI Weighted index Self-report 19 Yes 
  391 Peng et 
al.(2020) 
2020 Associations of 
MM with 
outcome 




Self-report 15 Yes 
  392 Perez et 
al.(2020)  
2020 Trajectory of 
MM 




Self-report 60 Yes 
  393 Perkins et 
al.(2004) 













  394 Pessini  et al. 
(2016) 









Self-report 8 Yes 
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  395 Petersen et 
al.(2019) 
2019 Associations of 
risk factors with 
MM 







  396 Pfortmueller 
et al.(2013)  












  397 Poitras et 
al.(2012)  
2012 Examination of 
MM measures 
France Europe Primary care All adults NA DBMA 
(French-
version) 
Weighted index Self-report 21 Yes 
  398 Portz et 
al.(2017) 





Hospitals Only older people Index 
score 
D’Hoor's CCI Weighted index Self-report 19 Yes 
  399 Pratt et 
al.(2018) 
2018 Examination of 
MM measures 





  400 Prazeres et 
al.(2015)  











  401 Prazeres et 
al.(2018)  
2018 Examination of 
MM measures 












  402 Pressley  et 
al.(1999) 
















  403 Prior et al. 
(2016)  
2016 Study of people 
with MM 




Self-report 39 Yes 
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  404 Prior et 
al.(2018) 
2018 Study of people 
with MM 




Self-report 39 Yes 
  405 Pruchno et 
al.(2016) 





Community Middle aged and 
older 




Self-report 5 Yes 
  406 Pylvalainen et 
al.(2019)  
2019 Examination of 
MM measures 
Finland Europe Community Middle aged and 
older 




Weighted index Self-report NA NA 
  407 Quah et 
al.(2017) 
2017 Associations of 
MM with 
outcome 




Self-report 14 Yes 
  408 Quail et 
al.(2011) 

















  409 Quan et al. 
(2011) 













  410 Quan et al. 
(2002) 









  411 Quan et al. 
(2005) 




Hospitals All adults NA CCI and 
Elixauser's CCI 





  412 Quinones et 
al.(2019) 








Self-report 7 Yes 
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  413 Quinones et 
al.(2016) 
2016 Patterns of MM USA North 
America 




Self-report 9 Yes 
  414 Quinones et 
al.(2018) 









Self-report 10 Yes 
  415 Quinones et 
al.(2011) 




Community Middle aged and 
older 




Self-report 7 Yes 
  416 Rafiq et 
al.(2019) 
2019 Associations of 
MM with 
outcome 
Sweden Europe Hospitals Middle aged and 
older 





  417 Ramiarina et 
al.(2008) 




Hospitals All adults NA Ramiarina's 
CCI 





  418 Ramond-
Roquin et 
al.(2016) 








Self-report 21 Yes 
  419 Randall et 
al.(2018) 
2018 Associations of 
MM with 
outcome 




Self-report 30 Yes 
  420 Ranstad et 
al.(2017)  
2017 Associations of 
MM with 
outcome 







  421 Ranstad et 
al.(2014)  
2014 Associations of 
MM with 
outcome 

















  422 Rast et 
al.(2014) 





Community Middle aged and 
older 




Self-report 5 Yes 
  423 Reinke et 
al.(2019) 




Primary care All adults NA Elixhauser's 
CCI 





  424 Ribeiro et 
al.(2018) 
2018 Associations of 








Self-report 8 Yes 
  425 Rose et al. 
(2018) 








Self-report 13 Yes 
  426 Roso-Llorach 
et al.(2018)  











  427 Rozzini et 
al.(2002)  
2002 Examination of 
MM measures 










  428 Ruel et 
al.(2014) 
2014 Trajectory of 
MM 




Self-report 8 Yes 
  429 Ruel et 
al.(2014) 
2014 Trajectory of 
MM 




Self-report 11 Yes 
  430 Russell et 
al.(2020) 
2020 Associations of 
risk factors with 
MM 




Self-report 7 Yes 
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  431 Ryan et 
al.(2018)  
2018 Trajectory of 
MM 
Ireland Europe Community Middle aged and 
older 




Self-report 16 Yes 
  432 Sasseville et 
al.(2019)  
2019 Examination of 
MM measures 
Ireland Europe Primary care Only older people 3+ Medication 
classes count, 
Chronic disease 
count Barnett et 
al.(2012) 





  433 Barnett et al. 
(2012)  
2012 Associations of 
risk factors with 
MM 









  434 Schafer et 
al.(2014)  









  435 Schafer et 
al.(2010)  









  436 Schamess et 
al.(2017) 















  437 Schilling et 
al.(2013)  
2013 Associations of 
MM with 
outcome 




Self-report 37 Yes 
  438 Schmidt et 
al.(2016)  
2016 Associations of 
















Self-report 11 Yes 
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  439 Schneeweiss 
et al.(2001) 




Community Only older people NA CCI (Romano, 
D’Hoore, Deyo, 
Ghali), CDS 





  440 Schneeweiss 
et al.(2003) 




Community Only older people NA CCI (Romano, 
Elixhauser), 
CDS 





  441 Schottker et 
al.(2016)  
2016 Associations of 
risk factors with 
MM 
Germany Europe Primary care Middle aged and 
older 





  442 Schuttner et 
al.(2020) 




Primary care All adults 2+ Chronic 
Condition 
Indicator 





  443 Schuz et 
al.(2011)  
2011 Study of people 
with MM 




Self-report 23 No 
  444 Schuz et 
al.(2015)  
2015 Study of people 
with MM 











  445 Schuz et 
al.(2016)  
2016 Study of people 
with MM 











  446 Schuz et 
al.(2014)  
2014 Study of people 
with MM 

















  447 Schuz et 
al.(2012)  
2012 Study of people 
with MM 











  448 Selim et 
al.(2004) 




Primary care All adults NA Comorbidity 
index (CI) 
Weighted index Self-report 36 Yes 
  449 Seo et 
al.(2017) 
2017 Associations of 
MM with 
outcome 
South Korea Asia Community Middle aged and 
older 




Self-report 15 Yes 
  450 Seo et 
al.(2019) 
2019 Associations of 
risk factors with 
MM 




Self-report 46 Yes 
  451 van den 
Bussche et al. 
(2011)  









  452 Shakib et 
al.(2016) 
2016 Study of people 
with MM 











  453 She et al. 
(2019) 




Self-report 22 Yes 
  454 Shih et 
al.(2015) 














  455 Shih et 
al.(2016) 




















  456 Shwartz et 
al.(1996) 













  457 Silay et 
al.(2017) 
2017 Associations of 
MM with 
outcome 





  458 Singer et 
al.(2019)  
2019 Trajectory of 
MM 
UK Europe Community Middle aged and 
older 




Self-report 25 Yes 
  459 Singh et 
al.(2019) 
2019 Associations of 
MM with 
outcome 




Self-report 5 Yes 
  460 Smith et 
al.(2008)  
2008 Study of people 
with MM 
Ireland Europe Primary care Only middle-aged 3+ Unclear Unclear NA Uncl
ear 
No 
  461 Spangenberg 
et al.(2011)  
2011 Associations of 
MM with 
outcome 




Self-report 25 Yes 
  462 St Sauver et 
al.(2015) 













  463 Stanley et 
al.(2017) 
2017 Examination of 
MM measures 





  464 Stanley et 
al.(2018) 
2018 Associations of 
MM with 
outcome 











  465 Starfield et 
al.(2003) 











  466 Steel et 
al.(2019) 
2019 Study of people 
with MM 









  467 Steinman et 
al.(2012) 
2012 Patterns of MM USA North 
America 









  468 Stenholm et 
al.(2015) 
2015 Associations of 
MM with 
outcome 




Self-report 7 Yes 
  469 Stepanova et 
al.(2015) 
2015 Associations of 








Self-report 13 Yes 
  470 Stickley et 
al.(2020) 









Self-report 9 Yes 
  471 Stokes et 
al.(2017) 
2017 Study of people 
with MM 









  472 Streit et 
al.(2014) 
2014 Associations of 
MM with 
outcome 
Switzerland Europe Primary care Middle aged and 
older 









  473 Strickland et 
al.(2018) 
2018 Study of people 
with MM 















  474 Stubbs et al. 
(2018) 
2018 Associations of 









Community Middle aged and 
older 




Self-report 13 Yes 
  475 Stukenborg et 
al.(2001) 




Hospitals All adults NA Deyo CCI, 
Elixhauser’s CI 





  476 Su et 
al.(2016) 
2016 Associations of 
MM with 
outcome 




Self-report 10 Yes 
  477 Subramaniam 
et al.(2019) 
2019 Study of people 
with MM 
Singapore Asia Primary care All adults 2+ Unclear Unclear NA Uncl
ear 
No 
  478 Sullivan et 
al.(2012) 
2012 Associations of 













  479 Sundararajan 
et al.(2004) 
2004 Examination of 
MM measures 
Australia Australasia Hospitals All adults NA Deyo' CCI 
(ICD-10 and 
ICD-9) 





  480 Sundararajan 
et al.(2007) 
2007 Examination of 
MM measures 









  481 Sundstrup et 
al.(2017) 









Self-report 8 Yes 
  482 Susser et 
al.(2008) 



















  483 Tai et 
al.(2006) 




Hospitals Only children NA Pediatric 
comorbidity 
model 














  484 Takahashi  et 
al.(2016) 
2016 Associations of 




Hospitals All adults NA Minnesota 
Medical Tiering 







  485 Taleshan et 
al.(2018) 
2018 Patterns of MM Denmark Europe Community All adults 2+ CCI + 4 
psychiatric 
disorders 
Weighted index Self-report 21 Yes 
  486 Tan et 
al.(2013) 
2013 Associations of 
MM with 
outcome 





  487 Tetzlaff et 
al.(2017) 
2017 Examination of 
MM measures 
Germany  Europe Community Only older people 3+ van den 
Bussche's 
measure 





  488 Thavorn et 
al.(2017) 














  489 Theou  et 
al.(2012) 





Community Only older people 2+ Unclear Unclear NA Uncl
ear 
No 
  490 Thompson  et 
al.(2015) 



















  491 Thygesen  et 
al.(2011) 
2011 Examination of 
MM measures 





  492 Tinetti et 
al.(2011) 









Self-report 5 Yes 
  493 Tinetti et 
al.(2012) 
















  494 Tinetti  et 
al.(2015) 













  495 Tinetti  et 
al.(2019) 




Primary care Only older people 3+ Unclear Unclear NA Uncl
ear 
No 
  496 Tooth et 
al.(2008) 
2008 Examination of 
MM measures 




Self-report 17 Yes 
  497 Troelstra et 
al.(2020) 









Self-report 26 Yes 
  498 Tyack et 
al.(2016) 
2016 Study of people 
with MM 




Self-report 25 No 
  499 Tyack et 
al.(2018) 
2018 Study of people 
with MM 




Self-report 25 Yes 
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  500 Tyack et 
al.(2018) 
2018 Study of people 
with MM 




Self-report 21 Yes 
  501 Umegaki et 
al.(2017) 
2017 Associations of 
MM with 
outcome 





  502 Valdivieso et 
al.(2018) 
2018 Study of people 
with MM 
Spain Europe Hospitals All adults NA Unclear Unclear NA Uncl
ear 
No 
  503 van den Brink 
et al.(2017) 













  504 van Walraven 
et al.(2009) 




Hospitals All adults NA Elixhauser's 
measure 





  505 van Zon et 
al.(2020) 








Self-report 8 Yes 
  506 Vancampfort 
et al.(2017) 
2017 Associations of 













Self-report 11 Yes 
  507 Vasilopoulos 
et al.(2014) 








Weighted index Self-report 19 Yes 
  508 Vassilaki et 
al.(2015) 




















  509 Vassilaki et 
al.(2016) 














  510 Vetrano et 
al.(2016) 
2016 Associations of 



























  511 Vila-Rodrigue 
et al.(2013) 
2013 Patterns of MM Canada North 
America 
Community All adults but not 
older people 




Self-report 12 Yes 
  512 Villarreal et 
al.(2015) 









Self-report 7 Yes 
  513 Violan et al. 
(2019) 









  514 Violan et al. 
(2014) 
2014 Associations of 
risk factors with 
MM 









  515 Vitry et 
al.(2009) 
2009 Examination of 
MM measures 















  516 Volaklis et 
al.(2018) 
2018 Study of people 
with MM 




Self-report 13 Yes 
  517 von Strauss et 
al.(2000) 




Self-report 15 Yes 
  518 Vos et 
al.(2013) 









Self-report 21 Yes 
  519 Vu et 
al.(2019) 
2019 Associations of 
MM with 
outcome 











  520 Wagner et 
al.(2019) 













  521 Wallace et 
al.(2016) 
2016 Examination of 
MM measures 


















  522 Wang et 
al.(2009) 









  523 Wang et al. 
(2018) 









Self-report 20 Yes 
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  524 Wang et al. 
(2017) 
2017 Associations of 
MM with 
outcome 




Self-report 17 Yes 
  525 Wei et al. 
(2019) 









Weighted index Self-report 81 Yes 
  526 Wei et al. 
(2018) 








(81) and simple 
count of 
diseases (12) 
Weighted index Self-report 81 Yes 
  527 Wei et al. 
(2016) 




Community All adults NA Multimorbidity 
weighted index  
Weighted index Self-report 81 Yes 
  528 Wei et al. 
(2019) 








CCI and disease 
count 
Weighted index Self-report 81 NA 
  529 Wei et al. 
(2018) 




Community All adults NA Multimorbidity 
weighted index, 
CCI and disease 
count 
Weighted index Self-report 81 NA 
  530 Wei et al. 
(2020) 

















  531 Welmer et al. 
(2012) 
2012 Associations of 
risk factors with 
MM 











  532 Whitson et al. 
(2016) 
2016 Patterns of MM USA North 
America 




Self-report 13 Yes 
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  533 Wijers et al. 
(2019) 
2019 Examination of 
MM measures 
Spain Europe Community Middle aged and 
older 





Self-report 21 Yes 
  534 Wikstrom et 
al. (2015) 
2015 Associations of 
risk factors with 
MM 
Finland Europe Community All adults but not 
older people 




Self-report 6 Yes 
  535 Williams et al. 
(2016) 









Self-report 9 Yes 
  536 Wister et al. 
(2015) 




Community Only older people 2+ Wister's 
measure 
Weighted index Self-report 19 Yes 
  537 Woldesemaya
t  et al. (2018) 




Self-report 18 Yes 
  538 Wong et al. 
(2016) 
2016 Associations of 














  539 Yang et al. 
(2014) 
2014 Trajectory of 
MM 




Self-report 4 Yes 
  540 Yao et al. 
(2020) 
2020 Associations of 
MM with 
outcome 
China Asia Community Middle aged and 
older 




Self-report 15 Yes 
  541 Yorke et al. 
(2017) 





Community Middle aged and 
older 




Self-report 7 Yes 
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  542 You et al. 
(2019) 
2019 Associations of 
MM with 
outcome 




Self-report 27 Yes 
  543 Zekry et al. 
(2012) 
2012 Examination of 
MM measures 




















  544 Zekry et al. 
(2010) 
2010 Examination of 
MM measures 


















  545 Zimmerman 
et al. (2017) 




Hospitals All adults 3+ Unclear Unclear NA Uncl
ear 
No 
  546 Zielinski  et 
al. (2011) 
2011 Associations of 
MM with 
outcome 













  547 Zhang et al. 
(2020) 
2020 Associations of 
risk factors with 
MM 




Self-report 15 Yes 
  548 Zhang et al. 
(1999) 









  549 Zulman et al. 
(2015) 














  550 Zielinski et al. 
(2009) 
2009 Examination of 
MM measures 





  551 Miller et al. 
(1992) 









  552 van den Brink 
et al. (2020) 















  553 Khanam et al. 
(2011) 









  554 Cornell et al. 
(2009) 
2009 Patterns of MM USA North 
America 









  555 Guerra et al. 
(2019) 


















  556 Peng et al. 
(2020) 
2020 Examination of 
MM measures 









  557 Wang et al. 
(2020) 









Weighted index Self-report 35 Yes 
  558 Canizares et 
al. (2018) 
2018 Associations of 




Community All adults but not 
older people 




Self-report 17 Yes 
  559 Cassell et al. 
(2018) 
2018 Prevalence of 
MM 









  560 Wang et al. 
(2014) 
2014 Prevalence of 
MM 




Self-report 40 Yes 
  561 Wong et al. 
(2019) 
2019 Associations of 
MM with 
outcome 




Self-report 5 Yes 
  562 Chung et al. 
(2015) 
2015 Associations of 
risk factors with 
MM 




Self-report 46 Yes 
  563 Nicholson et 
al. (2019) 
2019 Patterns of MM Canada North 
America 









  564 George et al. 
(2006) 
2006 Examination of 
MM measures 
Australia Australasia Hospitals Middle aged and 
older 











  565 Von Korff et 
al. (1992) 









  566 Puth et al. 
(2017) 
2017 Associations of 
risk factors with 
MM 




Self-report 17 Yes 
Abbreviations: MM: Multimorbidity. NA: Not Applicable. MM.Def: Definition of multimorbidity. No.Con: Number of conditions. Listing.Con: Listing of conditions. CCI: 
Charlson Comorbidity Index. CIRS-G: Cumulative Illness Rating Scale-Geriatric. CCS: Clinical Classification Software. ACG: Adjusted Clinical Group. CDS: Chronic 
Disease Score. QOF: Quality and Outcome Framework. MCS: Multisource Comorbidity Score. ICC: Individual Chronic Condition. PBDI: Pharmacy-Based Disease 
Indicator. GIC: Geriatric Index of Comorbdiity. MDBI: Medication-based Disease Burden Index. FCI: Functional Comorbidity Index. HRQoL-CI: Health-related Quality of 










Table S4: Cross-tabulation 
 
Characteristics Type of measure Chi-square test 





    
Trajectories 89% 11% 100% χ2=11⸱87 
p=0.008 
Outcome 78% 22% 100% 
Risk factors 93% 7% 100% 
Patterns 91% 9% 100% 
Examination of measures 16% 84% 100% 
Study of people with 
multimorbidity 
91% 9% 100% 
Study setting 
 
    
Community 86% 14% 100% χ2=153⸱60 
p=0.0004 
Primary care 74% 26% 100% 
Hospitals 22% 78% 100% 
Care homes 42% 58% 100% 
Source 
 
    
Self-report 89% 11% 100% χ2=57⸱00 
p=0.0004 








































Table S5: Risk of bias assessment (EPHPP domains and overall RoB assessment; and study-specific evaluation of clarity of reporting of multimorbidity 
measurement) 
 

















1 Aaby et al. (2019) Moderate High Moderate High Moderate High Moderate Unclear Moderate No 
2 Aarts et al. (2012) Moderate Moderate Moderate High Low Low Moderate Low Moderate Yes 
3 Aarts et al. (2011) Low High Moderate High Moderate Moderate Moderate Low Moderate No 
4 Aarts et al. (2011) Moderate Moderate Moderate High Low Low Moderate Low Moderate Yes 
5 Abizanda et al. (2014) Moderate Moderate Moderate High Moderate Moderate Moderate Low Moderate Yes 
6 Agborsangaya et al. (2012) Moderate Moderate Moderate High Moderate High Moderate Unclear Moderate Yes 
7 Agborsangaya et al. (2013) Moderate Moderate Moderate High Moderate High Moderate Unclear Moderate Yes 
8 Agborsangaya et al. (2014) Moderate Moderate Moderate High Moderate High Moderate Low Moderate Yes 
9 Ahrenfeldt et al. (2019) Low Moderate Moderate High Low High Moderate Low Moderate No 
10 Alimohammadian et al. 
(2017) 
Low Moderate Moderate High Low High Moderate Low Moderate Yes 
11 Alwhaibi et al. (2015) Low Moderate Moderate High Low High Moderate Low Moderate Yes 
12 Angst et al. (2002) Moderate Moderate Moderate High Low High High Unclear High No 
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13 Appa et al. (2014) Moderate Moderate Moderate High Moderate High Moderate Low Moderate Yes 
14 Adams (2017) Low Moderate Moderate High Moderate High Moderate Low Moderate Yes 
15 Adams et al. (2017) Low Moderate Moderate High Moderate High Moderate Low Moderate Yes 
16 Ahmadi et al. (2016) Low Moderate Moderate High Moderate High Moderate Unclear Moderate Yes 
17 Ahn et al. (2017) Low Moderate High High Moderate High Moderate Low High No 
18 Alonso et al. (2011) Low Moderate Moderate High Moderate Moderate Moderate Unclear Moderate Yes 
19 Alonso-Moran et al. (2015) Moderate Moderate Moderate High Moderate High Moderate Low Moderate Yes 
20 Alwhaibi et al. (2015) Low Moderate Moderate High Low High Moderate Low Moderate Yes 
21 Amaral et al. (2018) High Moderate Moderate High Moderate High Moderate Unclear Moderate Yes 
22 An et al. (2016) Low Moderate Moderate High Moderate High Moderate Unclear Moderate Yes 
23 Andersson et al.(2018) Moderate Moderate High High Moderate High Moderate Unclear Moderate No 
24 Andrade et al. (2010) Moderate Moderate High High Moderate High Moderate Unclear Moderate Yes 
25 Andrews et al. (2001) Moderate Moderate Moderate High Moderate High Moderate Unclear Moderate Yes 
26 Araujo et al. (2018) Low Moderate Low High Moderate High Moderate Low Moderate Yes 
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27 Adeniji et al. (2015) Moderate Moderate Moderate High Moderate High Moderate Low Moderate Yes 
28 Arnold-Reed et al. (2018) Moderate Moderate Moderate High Moderate High Moderate Low Moderate Yes 
29 Arokiasamy et al. (2015) Low Moderate Moderate High Moderate High Moderate Low Moderate Yes 
30 Ashworth et al. (2019) Low Moderate Moderate High Low Low Moderate Low Low Yes 
31 Arfken et al. (1998) High Moderate Moderate High Moderate High Moderate Low Moderate No 
32 Assari et al. (2015) Low Moderate Moderate High Moderate High Moderate Low Moderate Yes 
33 Assari et al. (2015) High Moderate Moderate High Moderate High Moderate Low Moderate Yes 
34 Aubert et al. (2019) Moderate Moderate Moderate High Moderate High Moderate Low Moderate No 
35 Holden et al. (2011) Low Moderate Moderate High Moderate High Moderate Low Moderate No 
36 Violan et al. (2013) Low Moderate Moderate High Moderate High Moderate Low Moderate Yes 
37 Sinnige et al.(2015) Low Moderate Moderate High Low Low Moderate Low Moderate Yes 
38 Christofoletti et al.(2018) Low Moderate Moderate High Moderate High Moderate Low Moderate Yes 
39 Aubert et al. (2019) Low Moderate Moderate High Low Low Moderate Low Low No 
40 Aubert et al.(2020) Low Moderate Moderate High Low Low Moderate Low Low No 
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41 Cornish et al.(2013) High Moderate Moderate High Moderate High Moderate Low Moderate No 
42 Zemedikun et al.(2018) Low Moderate Moderate High Moderate High Moderate Low Moderate Yes 
43 Wensing et al. (2001) Moderate Moderate Moderate High Moderate Moderate Moderate Unclear Moderate Yes 
44 Forjaz et al.(2015) Moderate Moderate Moderate High Moderate Moderate Moderate Low Moderate Yes 
45 Prazeres et al.(2016) Moderate Moderate Moderate High Moderate High Moderate Low Moderate Yes 
46 Mounce et al.(2018) Low Moderate Moderate High Moderate High Moderate Low Moderate Yes 
47 Taylor et al.(2010) Low Moderate Moderate High Low Low Moderate Low Low Yes 
48 Vancampfort et al.(2019) Low Moderate Moderate High Moderate High Moderate Low Moderate Yes 
49 Vancampfort et al.(2018) Low Moderate Moderate High Moderate High Moderate Low Moderate Yes 
50 Aubert et al.(2016) Moderate Moderate Moderate High Moderate Low Moderate Low Moderate Yes 
51 Autenrieth et al.(2013) Moderate Moderate Moderate High Moderate High Moderate Low Moderate Yes 
52 Bahat et al.(2013) High High High High High High Moderate Low High No 
53 Bahat et al.(2014) High High High High High High Moderate Low High No 
54 Bahler et al.(2015) Low Moderate Moderate High Moderate Low Moderate Low Moderate Yes 
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55 Vancampfort et al.(2017) Low Moderate Moderate High Moderate High Moderate Unclear Moderate Yes 
56 Bahrmann et al.(2019) Moderate Moderate Moderate High Moderate High Moderate Low Moderate Yes 
57 Balbale et al(2016) High Moderate Moderate High Moderate High Moderate Unclear Moderate No 
58 Banjare et al.(2014) Moderate Moderate Moderate High Moderate High Moderate Unclear Moderate Yes 
59 Bao et al.(2019) Low Moderate Moderate High Moderate Low Moderate Low Moderate Yes 
60 Barra et al.(2015) Moderate Moderate High High Moderate High Moderate Unclear Moderate No 
61 Bayliss et al.(2015) Low Moderate Moderate High Moderate Moderate Moderate Unclear Moderate Yes 
62 Bayliss et al.(2005) Moderate Moderate Moderate High Moderate Low Moderate Unclear Moderate Yes 
63 Bayliss et al.(2009) High Moderate Moderate High Moderate High Moderate Unclear Moderate No 
64 Bekic et al.(2019) High Moderate Moderate High Moderate High Moderate Unclear Moderate No 
65 Beloosesky et al.(2011) High Moderate Moderate High Moderate High Moderate Unclear Moderate Yes 
66 Bernard et al.(2016) High Moderate High High Moderate Low Moderate Low High No 
67 Bishop et al.(2018) High Moderate Low High Moderate High Moderate Low High No 
68 Biswas et al.(2019) Low Moderate Moderate High Moderate High Moderate Low Moderate No 
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69 Blakemore et al.(2016) Moderate Moderate Moderate High Moderate High Moderate Low Moderate No 
70 Blyth et al.(2008) Moderate Moderate Moderate High Moderate High Moderate Low Moderate Yes 
71 Bobo et al.(2016) Low Moderate Moderate High Moderate Low Moderate Low Moderate Yes 
72 Boeckxstaens et al.(2015) Moderate Moderate Moderate High Moderate High Moderate Low Moderate Yes 
73 Boeckxstaens et al.(2015) Moderate Moderate Moderate High Moderate High Moderate Low Moderate Yes 
74 Booth et al.(2014) Low Moderate Moderate High Moderate Low Moderate Unclear Moderate Yes 
75 Borson et al.(2010) High Moderate Moderate High Moderate High Moderate Unclear Moderate No 
76 Bottle et al.(2011) Low Moderate Moderate High Low Low Moderate Unclear Moderate Yes 
77 Bower et al.(2013) High Moderate Moderate High Moderate High Moderate Low Moderate Yes 
78 Bowling et al. (2019) Low Moderate Moderate High Moderate Low Moderate Low Moderate Yes 
79 Bravo (2002) Moderate Moderate Moderate High Moderate High Moderate Low Moderate No 
80 Brenk-Franz et al. (2017) High Moderate Moderate High Moderate High Moderate Low Moderate No 
81 Brett et al. (2013) Moderate Moderate Moderate High Moderate High Moderate Low Moderate Yes 
82 Brett et al. (2014) Moderate Moderate High High Moderate High Moderate Low Moderate Yes 
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83 Brilleman et al. (2013) Low Moderate Moderate High Moderate Moderate Moderate Low Moderate Yes 
84 Britt et al. (2008) Low Moderate High High Moderate Moderate Moderate Low Moderate Yes 
85 Broeiro-Goncalves (2019) Low Moderate High High Moderate Moderate Moderate Low Moderate Yes 
86 Bruce et al. (2010) High Moderate Moderate High Low High Moderate Unclear High No 
87 Buntinx et al. (2002) Moderate High High High High High Moderate Unclear High No 
88 Burgers et al. (2010) Low Moderate High High Moderate Low Moderate Low Moderate Yes 
89 Burke et al. (2017) Moderate Moderate Moderate High Moderate High Moderate Low Moderate Yes 
90 Buurman et al. (2016) Moderate Moderate Moderate High Moderate High Moderate Low Moderate Yes 
91 Byers et al. (2010) Low Moderate Moderate High Moderate Moderate Moderate Unclear Moderate No 
92 Byles et al. (2005) Moderate Moderate Moderate High Moderate Low Moderate Unclear Moderate No 
93 Byles et al. (2014) Low Moderate Moderate High Moderate High Moderate Low Moderate No 
94 Bynum et al. (2017) Low Moderate Moderate High Moderate Low Moderate Low Moderate Yes 
95 Bynum et al. (2004) Low Moderate Moderate High Moderate Low Moderate Unclear Moderate Yes 
96 Calderon-Larranaga et al. 
(2018) 
Moderate Moderate Moderate High Moderate High Moderate Low Moderate Yes 
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et al. (2017) 
Moderate Moderate Moderate High Low Low Moderate Low Moderate Yes 
98 Calderon-Larranaga et al. 
(2019) 
Moderate Moderate Moderate High Moderate High Moderate Low Moderate Yes 
99 Camargo-Casas et al. 
(2018) 
Moderate Moderate Moderate High Moderate High Moderate Unclear Moderate Yes 
100 Canevelli et al. (2019) High High High High Moderate High Moderate Low High Yes 
101 Capisizu et al. (2015) High High High High Moderate High High Unclear High No 
102 Caracciolo et al. (2013) Moderate Moderate Moderate High Moderate Low Moderate Unclear Moderate Yes 
103 Caramello et al. (2019) High Moderate High High Moderate High Moderate Low High No 
104 Carey et al. (2013) Low Moderate Moderate High Low Low Moderate Low Low Yes 
105 Cesari et al. (2006) High Moderate Moderate High Moderate High Moderate Unclear Moderate Yes 
106 Chamberlain et al. (2020) Low Moderate Moderate High Low Low Moderate Low Low Yes 
107 Chan et al. (2014) Moderate Moderate Moderate High Moderate High Moderate Low Moderate Yes 
108 Chapleski et al. (1997) High Moderate High High Moderate High Moderate Unclear High No 
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109 Chaplin et al. (2018) Low Low Moderate High Low High Low Low Low Yes 
110 Chapman et al. (2015) Moderate Moderate Moderate High Moderate High Moderate Unclear Moderate Yes 
111 Charlson et al. (2007) Moderate Moderate Moderate High Moderate Low Moderate Unclear Moderate No 
112 Charlson et al. (2008) Moderate Moderate Moderate High Moderate Low Moderate Unclear Moderate Yes 
113 Charlson et al. (1987) Moderate Moderate Moderate High Moderate Low Moderate Unclear Moderate Yes 
114 Charlson et al. (2014) Moderate Moderate Moderate High Moderate Low Moderate Unclear Moderate Yes 
115 Chaudhry et al. (2005) Moderate Moderate Moderate High Moderate High Moderate Unclear Moderate Yes 
116 Chen et al. (2018) Low Moderate High High Low Low Moderate Low Low Yes 
117 Chen et al. (2018) Low Moderate Moderate High Moderate High Moderate Low Moderate Yes 
118 Chen et al. (2011) Low Moderate Moderate High Moderate High Moderate Unclear Moderate Yes 
119 Cheung et al. (2013) Moderate Moderate Moderate High Moderate High Moderate Unclear Moderate Yes 
120 Chin et al. (2019) High High High High Moderate High High Low High Yes 
121 Chong et al. (2012) Moderate Moderate Moderate High Moderate Moderate Moderate Unclear Moderate Yes 
122 Chow et al. (2014) Low Moderate Moderate High Moderate Low Moderate Low Moderate No 
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123 Chu et al. (2018) Low Moderate Moderate High Moderate Moderate Moderate Low Moderate Yes 
124 Chudasama et al. (2019) Moderate Moderate Low High Moderate Low Moderate Low Moderate Yes 
125 Cimarras-Otal et al. (2014) Low Moderate Moderate High Moderate High Moderate Low Moderate Yes 
126 Clerencia-Sierra et al. 
(2015) 
High High Moderate High High High Moderate Unclear High No 
127 Chen et al. (2014) Moderate Moderate Moderate High Moderate Low Moderate Unclear Moderate Yes 
128 Chen et al. (2019) High High Moderate High Moderate High Moderate Unclear High No 
129 Chen et al. (2010) High Moderate High High Moderate High Moderate Unclear High No 
130 Cheng et al. (2020) High Moderate Moderate High Moderate High Moderate Unclear Moderate No 
131 Chin et al. (2016) Moderate Moderate Moderate High Moderate Low Moderate Low Moderate Yes 
132 Clark et al. (2018) Moderate Moderate High High High Low Moderate Low High No 
133 Collins et al. (2018) High Moderate Moderate High Moderate High Moderate Low Moderate Yes 
134 Contant et al. (2019) Low Low Moderate High Moderate Low Moderate Low Low Yes 
135 Corrao et al. (2017) Low Moderate Moderate High Moderate Low Moderate Low Moderate Yes 
136 Formiga et al. (2016) High Moderate Moderate High Moderate High Moderate Low Moderate No 
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137 Fortin et al. (2006) High High Moderate High Moderate High Moderate Unclear High No 
138 Agrawal et al. (2016) Low Moderate Moderate High Moderate High Moderate Unclear Moderate Yes 
139 Fortin et al. (2007) High High High High Moderate High Moderate Low High Yes 
140 Gorup et al. (2017) High High High High Moderate High Moderate Low High No 
141 Griffith et al. (2018) Moderate High High High Moderate High Moderate Unclear High No 
142 Gu et al. (2018) Moderate Moderate Moderate High Moderate High Moderate Low Moderate Yes 
143 Guido et al. (2014) High High High High Moderate High Moderate Low High No 
144 Gunn et al. (2012) Low Moderate Moderate High Moderate High Moderate Low Moderate Yes 
145 Han et al. (2013) High High Moderate High Moderate High Moderate Unclear High No 
146 Hanlon et al. (2018) Low Moderate Moderate High Low Low Moderate Low Low Yes 
147 Incalzi et al. (1997) High Moderate Moderate High High High Moderate Unclear High No 
148 Jansa et al. (2010) Moderate Moderate Moderate High Moderate High Moderate Low Moderate Yes 
149 Jantsch et al. (2018) Moderate Moderate Moderate High Moderate High Moderate Low Moderate Yes 
150 John et al. (2003) Moderate High Moderate High Low High Moderate Low High No 
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151 Johnson-Lawrence et al. 
(2017) 
Low Moderate Moderate High Moderate High Moderate Low Moderate Yes 
152 Johnston et al. (2019) Moderate Moderate Moderate High Moderate High Moderate Low Moderate No 
153 Jones et al. (2016) Low Moderate Moderate High Low Low Moderate Unclear Moderate Yes 
154 Jovic et al. (2016) Moderate Moderate Moderate High Moderate High Moderate Low Moderate Yes 
155 Jovic et al. (2016) Moderate Moderate Moderate High Moderate High Moderate Low Moderate Yes 
156 Juul-Larsen et al. (2020) High Moderate Moderate High Moderate High Moderate Low Moderate Yes 
157 Hudon et al. (2008) Low Moderate Moderate High Low Low Moderate Low Low Yes 
158 Hussain et al. (2015) Moderate Moderate High High Moderate Low Moderate Low Moderate Yes 
159 Hussin et al. (2019) High Moderate Moderate High Moderate High Moderate Low Moderate Yes 
160 Hutchinson et al. (2015) High Moderate High High Moderate High Moderate Low High No 
161 Ie et al. (2017) High High Moderate High Moderate Low Moderate Low High Yes 
162 Ishizaki et al. (2019) Moderate Moderate Low High Moderate High Moderate Unclear Moderate Yes 
163 Jackson et al. (2015) Low Moderate Low High Moderate High Moderate Low Moderate Yes 
164 Jacobi et al. (2004) Low Moderate High High Moderate Low Moderate Unclear Moderate Yes 
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165 Januel et al. (2011) Moderate Moderate Moderate High Moderate Low Moderate Low Moderate Yes 
166 Danon-Hersch et al. (2012) Moderate High Moderate High Moderate High Moderate Low Moderate Yes 
167 de Heer et al. (2013) Moderate Moderate Moderate High Moderate High Moderate Unclear Moderate Yes 
168 de Souto Barreto et al. 
(2014) 
Low Moderate High High Moderate High Moderate Low High No 
169 Demirchyan et al. (2013) High Moderate Low High Moderate High Moderate Low High No 
170 Fabbri et al. (2015) Moderate Moderate High High Moderate High Moderate Unclear Moderate Yes 
171 Fabbri et al. (2016) High Moderate Moderate High Moderate High Moderate Unclear Moderate Yes 
172 Farley et al. (2006) Low Moderate Moderate High Moderate Low Moderate Unclear Moderate Yes 
173 Feng et al. (2018) Low Moderate Moderate High Moderate Low Moderate Low Moderate Yes 
174 Fergusson et al. (1993) High Moderate High High Moderate High Moderate Unclear High No 
175 Ferreira Agreli et al (2017) Moderate Moderate Moderate High Moderate High Moderate Unclear Moderate No 
176 Fillenbaum et al. (2000) Low Moderate Moderate High Moderate High Moderate Unclear Moderate Yes 
177 Finney Rutten et al. (2016) Moderate High Moderate High High High Moderate Low High No 
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178 Ford et al. (2019) Low Low Moderate High Low Low Moderate Low Low No 
179 Kadam et al. (2007) Moderate Moderate Moderate High Moderate High Moderate Low Moderate No 
180 Kaneko et al. (2019) Moderate Moderate High High Moderate Low Moderate Low Moderate No 
181 Kang et al. (2017) High Moderate Moderate High Moderate High Moderate Low Moderate Yes 
182 Gruneir et al. (2016) Low Moderate High High Moderate Low Moderate Low Moderate Yes 
183 Gandhi et al. (2020) Moderate Moderate Moderate High High High Moderate Low Moderate Yes 
184 Corrao et al. (2019) Moderate Moderate High High High High Moderate Low High No 
185 Corrao et al.(2020) Moderate Moderate Moderate High Moderate High Moderate Low Moderate No 
186 Cortaredona et al.(2017) High Moderate Moderate High Moderate Low Moderate Unclear Moderate Yes 
187 Costa et al. (2018) High Moderate Moderate High Moderate High Moderate Unclear Moderate Yes 
188 Cramm et al. (2018) High Moderate High High Moderate High Moderate Low High No 
189 Crooks et al. (2016) Moderate Moderate High High Moderate Low Moderate Low Moderate Yes 
190 Crooks et al. (2015) Moderate Moderate High High Moderate Low Moderate Low Moderate Yes 
191 Dankel et al. (2018) Moderate High High High Moderate High Moderate Low High Yes 
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192 Dankel et al. (2017) Moderate Moderate High High Moderate High Moderate Unclear Moderate Yes 
193 Dattalo et al. (2017) Low Moderate Moderate High Low Low Moderate Unclear Moderate Yes 
194 de Carvalho et al. (2018) Low Moderate Low High Moderate High Moderate Low Moderate Yes 
195 de Souza Leal Neto et 
al.(2016) 
High Moderate Moderate High Moderate High Moderate Unclear Moderate Yes 
196 Verghese et al. (2016) High Moderate High High Moderate High Moderate Unclear High No 
197 Der-Martirosian et al. 
(2013) 
Moderate Moderate High High Moderate High Moderate Unclear Moderate No 
198 Rizzuto et al. (2017) High Moderate High High Moderate Moderate Moderate Low Moderate Yes 
199 Rivera-Almaraz et al. 
(2018) 
High Moderate Moderate High Moderate Moderate Moderate Low Moderate No 
200 Schneider et al. (2012) High Moderate Moderate High High Moderate Moderate Unclear Moderate Yes 
201 Schneeweiss et al. (2004) Low Moderate Moderate High Low Low Low Unclear Low Yes 
202 Sara et al.(2018) High Moderate Moderate High Moderate High Moderate Low Moderate Yes 
203 Dhalwani et al. (2017) Moderate Moderate Low High Moderate High Moderate Low Moderate Yes 
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204 Di Bari et al. (2006) High Moderate Moderate High Moderate High Moderate Low Moderate Yes 
205 Dias et al. (2015) High Moderate Moderate High Moderate High Moderate Low Moderate Yes 
206 DiBonaventura et al. (2018) Moderate Moderate Moderate High Moderate Moderate Moderate Low Moderate No 
207 Diederichs et al.(2012) Moderate Low Moderate High Low Low Moderate Unclear Moderate Yes 
208 Diez-Manglano et al.(2015) High Moderate Moderate High Moderate High Moderate Low Moderate Yes 
209 Dong et al. (2013) Low Moderate Moderate High Moderate Low Moderate Low Moderate No 
210 Donze et al.(2013) Moderate High Moderate High High Low Moderate Low High No 
211 Drewes et al.(2011) Moderate Moderate High High Moderate Low Moderate Low Moderate Yes 
212 Droomers et al. (2004) Moderate High High High High High Moderate Low High No 
213 Eakin et al. (2007) Moderate Low Low High Low Moderate Moderate Low Low Yes 
214 Sangha et al. (2003) Moderate Moderate Moderate High Low Moderate Moderate Unclear Moderate No 
215 Salman et al. (2019) Moderate Moderate Moderate High Moderate Moderate Moderate Low Moderate Yes 
216 Salisbury et al. (2018) Low Low Moderate High Moderate Moderate Moderate Low Moderate No 
217 Rius et al. (2008) Low Low Low High Low High Moderate Unclear Low Yes 
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218 Elixhauser et al. (1998) Low Moderate High High Low Low Moderate Unclear Low Yes 
219 Eton et al. (2017) High Moderate High High Low High Moderate Low High No 
220 Fabbri et al. (2015) High Moderate Moderate High Moderate High Moderate Low Moderate Yes 
221 Feng et al. (2018) Low Moderate Moderate High Moderate High Moderate Low Moderate Yes 
222 Ferrer et al. (2017) High Moderate High High Moderate Moderate Moderate Low Moderate Yes 
223 Ferro et al. (2019) High Moderate High High Moderate High Moderate Low High No 
224 Foguet-Boreu et al. (2015) Low High High High Moderate Moderate Moderate Unclear High No 
225 Fortin et al.(2016) High Moderate Moderate High Moderate Moderate Moderate Unclear Moderate Yes 
226 Fortin et al.(2005) Moderate Moderate High High Moderate High Moderate Unclear Moderate Yes 
227 Fortin et al.(2014) Low Moderate Low High Moderate Moderate Moderate Low Moderate Yes 
228 Fortin et al. (2005) Moderate Moderate Low High Moderate Moderate Moderate Unclear Moderate Yes 
229 Fortin et al. (2010) Low Moderate High High Moderate Moderate Moderate Low Moderate Yes 
230 Fortin et al. (2017) Low Moderate Moderate High Moderate Low Moderate Unclear Moderate Yes 
231 Fraccaro et al. (2016) Low Moderate Moderate High Moderate Low Moderate Unclear Moderate No 
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232 Fuchs et al. (1998) Moderate Moderate Moderate High Moderate Low Moderate Unclear Moderate No 
233 Fung et al. (2008) Low Moderate Moderate High Moderate High Moderate Low Moderate Yes 
234 Gadermann et al. (2012) Moderate Moderate High High Moderate Moderate Moderate Low Moderate No 
235 Gagne et al. (2011) Low Moderate High High Moderate Low Moderate Unclear Moderate Yes 
236 Galenkamp et al. (2011) Low Moderate High High Moderate High Moderate Unclear High No 
237 Galenkamp et al. (2016) Low Moderate Moderate High Moderate High Moderate Unclear Moderate Yes 
238 Gallegos-Carrillo et 
al.(2009) 
Moderate Moderate Moderate High Moderate High Moderate Unclear Moderate No 
239 Gallo et al.(2016) Low Moderate Moderate High High High Moderate Low High No 
240 Gamma et al. (2001) High Moderate High High Moderate High Moderate Unclear High No 
241 Gaulin et al.(2019) Low Moderate Moderate High Low Low Moderate Unclear Moderate Yes 
242 Gawron et al.(2020) Low Moderate Moderate High Moderate Low Moderate Low Moderate No 
243 Ge et al. (2018) Moderate Moderate High High Moderate High Moderate Unclear Moderate Yes 
244 Ge et al. (2019) Moderate Moderate Moderate High Moderate High Moderate Unclear Moderate Yes 
245 Gibbons et al. (2013) Moderate Moderate Moderate High Moderate High Moderate Unclear Moderate Yes 
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246 Gili et al. (2010) Low Moderate High High Moderate High Moderate Unclear High No 
247 Gnadinger et al. (2018) Low Moderate High High Moderate High Moderate Low High No 
248 Excoffier et al.(2018) Moderate Moderate High High Moderate High Moderate Low Moderate Yes 
249 Turner Goins et al.(2019) Moderate Moderate Moderate High Moderate Moderate Moderate Unclear Moderate No 
250 Gould et al.(2016) Moderate Moderate Moderate High High High Moderate Unclear Moderate Yes 
251 Griffith et al.(2019) Low Low High High Low Low Moderate Low Low Yes 
252 Habib et al.(2014) Moderate Moderate Moderate High Moderate High Moderate Unclear Moderate No 
253 Harris et al.(2016) High Moderate High High Moderate Moderate Moderate Unclear Moderate Yes 
254 Harrison et al.(2017) Low Moderate High High Moderate Low Moderate Unclear Moderate No 
255 Harrison et al.(2012) High Moderate Low High Moderate High Moderate Unclear High No 
256 Hayek et al.(2017) Low Moderate Moderate High Moderate High Moderate Unclear Moderate Yes 
257 Heller et al.(2009) Low Moderate High High Moderate High Moderate Unclear High No 
258 Helvik et al.(2013) High Moderate High High Moderate High Moderate Low High No 
259 Henninger et al.(2012) Moderate Moderate High High Moderate High Moderate Unclear Moderate No 
95 
 

















260 Hernandez et al.(2019) Moderate Moderate Moderate High High High Moderate Unclear Moderate Yes 
261 Hillen et al.(2017) Low Moderate High High High High Moderate Unclear High No 
262 Ho et al.(2014) Moderate Moderate High High Low Low Moderate Low Moderate Yes 
263 Holman et al.(2005) Low Moderate High High Low Low Moderate Unclear Low Yes 
264 Hopman et al.(2016) High Moderate Moderate High High High Moderate Low High No 
265 Hu et al.(2019) Low Moderate High High Low Low Moderate Low Low Yes 
266 Huang et al.(2019) High Moderate Moderate High Moderate High Moderate Unclear Moderate Yes 
267 Hudon et al.(2012) High Moderate Moderate High Moderate High Moderate Low Moderate Yes 
268 Katikireddi et al.(2017) Low Moderate Moderate High Moderate High Moderate Low Moderate Yes 
269 Kenning et al.(2015) High Moderate Moderate High Moderate High Moderate Low Moderate Yes 
270 Khan et al.(2010) Low Moderate Moderate High Low Low Moderate Low Low Yes 
271 Khan et al.(2019) Low Moderate Low High Low High Moderate Low Low Yes 
272 Ki et al. (2017) Low Moderate Moderate High Low Low Moderate Unclear Moderate Yes 
273 Kil et al. (2012) Low Moderate High High Moderate Low Moderate Unclear Moderate Yes 
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274 Kilgore et al. (2012) High Moderate High High Moderate Moderate Moderate Unclear Moderate No 
275 Kiliari et al. (2013) High Moderate High High Moderate Moderate Moderate Low Moderate No 
276 Kim et al. (2012) Moderate Moderate High High Moderate High Moderate Low Moderate Yes 
277 Kim et al. (2018) Low Moderate Low High Moderate Low Moderate Low Low Yes 
278 Kim et al. (2018) High Moderate High High Moderate Moderate Moderate Low Moderate Yes 
279 King et al.(2018) Moderate Moderate Moderate High Moderate High Moderate Unclear Moderate Yes 
280 Kingston et al. (2018) Low Moderate High High Moderate High Moderate Unclear High Yes 
281 Koyanagi et al.(2018) Low Moderate Moderate High Moderate Low High Low Moderate Yes 
282 Kriegsman et al. (2004) Moderate Moderate Moderate High Moderate High Moderate Unclear Moderate Yes 
283 Kristensen et al. (2019) Low Moderate Moderate High Moderate High Moderate Low Moderate Yes 
284 Kristensen et al. (2019) Moderate Moderate Moderate High Moderate High Moderate Low Moderate Yes 
285 Kumar et al. (2016) Low Moderate Moderate High Moderate Low Moderate Unclear Moderate Yes 
286 Kunna et al. (2017) Low Moderate Low High Moderate Low High Low Low Yes 
287 Kusumastuti et al. (2017) Low Moderate High High Moderate High Moderate Unclear High No 
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288 Kuwornu et al. (2014) Moderate Moderate High High Moderate Low Moderate Low Moderate Yes 
289 Lai et al. (2019) Low Moderate High High Moderate Low Moderate Low Moderate Yes 
290 Lai et al. (2018) High Moderate Moderate High Moderate High Moderate Low Moderate Yes 
291 Laires et al. (2019) Low Moderate Moderate High Moderate High Moderate Unclear Moderate Yes 
292 Landi et al. (2016) High Moderate Moderate High Moderate Moderate Moderate Low Moderate Yes 
293 Landi et al. (2010) High Moderate Low High Moderate Moderate Moderate Unclear Moderate Yes 
294 Lang et al. (2015) Moderate Moderate Moderate High Moderate Moderate Moderate Low Moderate Yes 
295 Langsted et al. (2020) Low Moderate High High High Low Moderate Low High No 
296 Laux et al. (2008) Low Moderate High High High Low Moderate Low High No 
297 Lawson et al. (2013) Low Moderate High High Moderate Moderate Moderate Low Moderate Yes 
298 Le Cossec et al. (2016) Low Moderate Moderate High Moderate Moderate Moderate Low Moderate Yes 
299 Lee et al. (2020) High Moderate Moderate High High High Moderate Low High No 
300 Lee et al. (2016) Moderate Moderate Moderate High Moderate High Moderate Low Moderate Yes 
301 Lee et al. (2007) Low Moderate High High Low Low Moderate Low Low Yes 
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302 Lee et al. (2018) Low Moderate High High High Low Moderate Unclear High No 
303 Lenzi et al. (2016) Low Moderate Moderate High Moderate Low Moderate Low Moderate Yes 
304 LePage et al. (2014) Low Moderate High High Moderate Low Moderate Low Moderate No 
305 Li et al. (2016) Low Low Moderate High Moderate High Moderate Low Moderate Yes 
306 Li et al. (2019) Low Moderate Low High Moderate Moderate Moderate Low Moderate No 
307 Librero et al. (1999) Low Moderate High High Moderate Low Moderate Unclear Moderate No 
308 LiuUnclearAmbrose et al. 
(2010) 
High Moderate Moderate High High High Moderate Low High No 
309 Lobo-Escolar et al. (2008) Low Moderate High High High High Moderate Unclear High Yes 
310 Loprinzi (2015) Moderate Moderate Moderate High Moderate High Moderate Unclear Moderate Yes 
311 Loprinzi (2017) Moderate Moderate Moderate High High High Moderate Unclear Moderate Yes 
312 Lorem et al. (2016) Moderate Moderate Moderate High High High Moderate Unclear Moderate Yes 
313 Low et al. (2019) Low Moderate Moderate High Low Low Moderate Low Low Yes 
314 Lu et al. (2011) Low High Moderate High Low Low Moderate Unclear Low Yes 
315 Lujic et al. (2017) Low Moderate Moderate High Low High Moderate Low Moderate Yes 
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316 Lupianez-Villanueva et 
al.(2018) 
Moderate Moderate Moderate High Moderate High Moderate Low Moderate Yes 
317 Zhou et al. (2018) Moderate Moderate Moderate High Moderate Low High Low Moderate Yes 
318 Zhang et al. (2019) Low Moderate Moderate High Moderate High Moderate Low Moderate Yes 
319 Yamada et al. (2015) High Moderate Moderate High Low High Moderate Low High No 
320 Wong et al. (2010) High Moderate Moderate High Moderate High Moderate Unclear Moderate Yes 
321 White (2018) Moderate Moderate Moderate High Moderate High Moderate Low Moderate Yes 
322 Weimann et al. (2016) Low Moderate Low High Moderate High Moderate Low Moderate Yes 
323 Wei et al. (2019) Low Moderate Moderate High Moderate High Moderate Unclear Moderate Yes 
324 Wang et al. (2017) Low Moderate Low High Moderate High Moderate Low Moderate Yes 
325 Wang et al. (2017) High Moderate High High Moderate High Moderate Low High No 
326 Wang et al. (2007) High Moderate High High Moderate Low Moderate Unclear High No 
327 Wang et al. (2019) Moderate Moderate Moderate High Moderate High Moderate Low Moderate No 
328 Walker et al. (2007) Moderate Moderate Moderate High Moderate High Moderate Unclear Moderate Yes 
329 Wade et al. (2019) Moderate Moderate Moderate High Moderate High Moderate Unclear Moderate Yes 
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330 Maciejewski et al. (2019) Low Moderate Moderate High Moderate High Moderate Unclear Moderate Yes 
331 MacKnight et al. (2001) Moderate High High High High Low Moderate Unclear High No 
332 Marengoni et al. (2016) Moderate Moderate High High Moderate High Moderate Low Moderate Yes 
333 Marengoni et al. (2009) Moderate Moderate High High Moderate High Moderate Unclear Moderate Yes 
334 Déruaz-Luyet et al. (2017) Moderate Moderate High High Moderate Low Moderate Low Moderate Yes 
335 Marengoni et al. (2009) Moderate Moderate High High Moderate High Moderate Low Moderate Yes 
336 Marques et al. (2018) Low Moderate Moderate High Moderate High Moderate Low Moderate Yes 
337 Martin-Garcia et al. (2013) High Moderate Moderate High Moderate High Moderate Low Moderate Yes 
338 Martinez-Velilla et al. 
(2014) 
High Moderate Moderate High Moderate High Moderate Low Moderate No 
339 Mavaddat et al. (2014) Low Moderate Moderate High Moderate High Moderate Low Moderate Yes 
340 Mazzella et al. (2010) Moderate Moderate Moderate High Moderate High Moderate Low Moderate No 
341 McDaid et al. (2013) Low Moderate High High Moderate High Moderate Low High Yes 
342 Md Yusof et al. (2010) High Moderate Moderate High Moderate High Moderate Low Moderate Yes 
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343 Melis et al. (2014) High Moderate Moderate High Moderate High Moderate Unclear Moderate Yes 
344 Mercer et al. (2016) Low Low Moderate High Low Low Moderate Low Low No 
345 Min et al. (2007) High Moderate High High Moderate High Moderate Unclear High Yes 
346 Min et al. (2014) Moderate Moderate High High Low Low Moderate Low Moderate Yes 
347 Mnatzaganian et al. (2012) Low Moderate High High Low Low Moderate Unclear Low Yes 
348 Mokraoui et al. (2016) Moderate Moderate Moderate High High High Moderate Low Moderate Yes 
349 Momtaz et al. (2010) Moderate Moderate Moderate High Moderate High Moderate Unclear Moderate Yes 
350 Mondor et al. (2018) Low Moderate Low High Moderate High Moderate Low Moderate Yes 
351 Mondor et al. (2016) Low Moderate Moderate High Low Low Moderate Low Low Yes 
352 Montes et al. (2020) High Moderate Moderate High Low Low Moderate Low Moderate Yes 
353 Moore et al. (2014) Low Moderate High High Moderate Low Moderate Unclear Moderate No 
354 Mori et al. (2019) Low Moderate High High Moderate Low Moderate Low Moderate No 
355 Mortsiefer et al (2017) High Moderate High High Moderate High Moderate Low High No 
356 Mueller-Schotte et al. 
(2020) 
Low Moderate Moderate High Low High Moderate Low Moderate Yes 
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357 Muggah et al. (2012) Low Moderate High High Moderate Low Moderate Low Moderate No 
358 Mukherjee et al. (2011) Moderate Moderate High High Moderate Low Moderate Unclear Moderate No 
359 Nagel et al. (2017) High Moderate Moderate High Moderate High Moderate Low Moderate Yes 
360 Nagel et al. (2008) Low Moderate Low High Moderate High Moderate Low Moderate Yes 
361 Nagl et al. (2012) High Moderate High High Moderate High Moderate Low High No 
362 Naithani et al. (2010) High Moderate High High Moderate High Moderate Unclear High No 
363 Narayan et al. (2017) Low Moderate Moderate High Low Low Moderate Low Low Yes 
364 New et al. (2017) High Moderate High High Moderate Low Moderate Low High No 
365 Nguyen et al. (2019) High Moderate Moderate High Moderate High Moderate Low Moderate Yes 
366 Niedzwiedz et al. (2019) Moderate Moderate High High Moderate Low Moderate Unclear Moderate Yes 
367 Nilssen et al. (2014) Low Moderate High High Moderate Low Moderate Unclear Moderate Yes 
368 Nobrega et al. (2009) High High High High Moderate High Moderate Unclear High No 
369 Nunes et al. (2016) Moderate Moderate Moderate High Moderate High Moderate Low Moderate Yes 
370 Nunes et al. (2017) Low Moderate Moderate High Low High Moderate Low Moderate Yes 
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371 Nunes et al.(2015) Moderate Moderate Moderate High Moderate High Moderate Low Moderate Yes 
372 Nutzel  et al.(2014) Moderate Moderate Low High Moderate High Moderate Low Moderate Yes 
373 Olaya  et al.(2017) Low Moderate Moderate High Moderate High Moderate Low Moderate Yes 
374 Olaya  et al.(2017) Low Moderate Moderate High Moderate High Moderate Low Moderate Yes 
375 Olivares  et al.(2017) High Moderate Moderate High Moderate High Moderate Low Moderate No 
376 Olsson et al.(2005) High Moderate Moderate High Low High Moderate Low High Yes 
377 Ou et al.(2016) Low Moderate Moderate High Moderate High Moderate Low Moderate Yes 
378 Pache et al.(2015) Moderate Moderate Moderate High Moderate High Moderate Low Moderate Yes 
379 Paddison et al.(2015) Low Moderate Moderate High Moderate High Moderate Low Moderate No 
380 Park et al. (2018) Moderate Moderate Moderate High Moderate High Moderate Low Moderate No 
381 Park et al. (2014) Moderate Moderate Moderate High Moderate High Moderate Low Moderate No 
382 Parker et al.(2003) High Moderate Moderate High Moderate Low Moderate Unclear Moderate No 
383 Parkerson et al.(1993) High Moderate Moderate High Moderate Low Moderate Unclear Moderate Yes 
384 Patel et al.(2006) Moderate Moderate High High Moderate High Moderate Unclear Moderate No 
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385 Pati et al.(2016) High Moderate Moderate High Moderate High Moderate Low Moderate Yes 
386 Pati et al.(2019) Moderate Moderate Moderate High Moderate Moderate Moderate Low Moderate Yes 
387 Pati et al.(2017) Moderate Moderate Moderate High Moderate Moderate Moderate Unclear Moderate Yes 
388 Patrick et al.(2001) High Moderate High High Moderate High Moderate Unclear High No 
389 Payne et al.(2013) Low Moderate Moderate High Moderate Low Moderate Unclear Moderate Yes 
390 Peng et al.(2014) High High High High High High Moderate Low High No 
391 Peng et al.(2020) Moderate Moderate Moderate High Moderate High Moderate Low Moderate Yes 
392 Perez et al.(2020) Moderate Moderate Moderate High Moderate Moderate Moderate Low Moderate Yes 
393 Perkins et al.(2004) Moderate Moderate Moderate High Moderate Low Moderate Unclear Moderate Yes 
394 Pessini  et al. (2016) Moderate High High High High High Moderate Unclear High Yes 
395 Petersen et al.(2019) Moderate Moderate Moderate High Moderate High Moderate Low Moderate No 
396 Pfortmueller et al.(2013) Moderate Moderate High High High High Moderate Unclear High No 
397 Poitras et al.(2012) High Low Moderate High Low Low Moderate Low Low Yes 
398 Portz et al.(2017) High Moderate High High Moderate Low Moderate Low High Yes 
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399 Pratt et al.(2018) Low Moderate Moderate High Low Low Moderate Low Low Yes 
400 Prazeres et al.(2015) Moderate Moderate Moderate High Moderate Low Moderate Low Moderate Yes 
401 Prazeres et al.(2018) Moderate Moderate High High High Low Moderate Low High Yes 
402 Pressley  et al.(1999) Low Moderate High High Moderate Low Moderate Unclear Moderate No 
403 Prior et al. (2016) Low Moderate Moderate High Moderate Low Moderate Unclear Moderate Yes 
404 Prior et al.(2018) Low Moderate Moderate High Moderate High Moderate Low Moderate Yes 
405 Pruchno et al.(2016) Moderate Moderate Moderate High Moderate High Moderate Unclear Moderate Yes 
406 Pylvalainen et al.(2019) Low Moderate Moderate High Moderate Low Moderate Unclear Moderate Yes 
407 Quah et al.(2017) High Moderate Moderate High Moderate Moderate Moderate Low Moderate Yes 
408 Quail et al.(2011) Moderate Moderate Moderate High Moderate Low Moderate Low Moderate Yes 
409 Quan et al. (2011) Low Moderate Moderate High Moderate Low Moderate Unclear Moderate Yes 
410 Quan et al. (2002) Moderate Moderate Moderate High Moderate Low Moderate Unclear Moderate Yes 
411 Quan et al. (2005) Low Low Moderate High Low Low Moderate Unclear Low Yes 
412 Quinones et al.(2019) Moderate Moderate Moderate High Moderate Moderate Moderate Unclear Moderate Yes 
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413 Quinones et al.(2016) Low Moderate High High Moderate High Moderate Unclear High Yes 
414 Quinones et al.(2018) Moderate Moderate High High Moderate Low Moderate Low Moderate Yes 
415 Quinones et al.(2011) Low Moderate Moderate High Low High Moderate Unclear Moderate Yes 
416 Rafiq  et al.(2019) Moderate Low High High Low Moderate Moderate Low Moderate No 
417 Ramiarina et al.(2008) Moderate Moderate Moderate High Moderate Low Moderate Unclear Moderate Yes 
418 Ramond-Roquin et 
al.(2016) 
Moderate Moderate Moderate High Moderate High Moderate Low Moderate Yes 
419 Randall et al.(2018) Low Moderate High High Moderate Low Moderate Low Moderate Yes 
420 Ranstad et al.(2017) Low Moderate High High Moderate Moderate Moderate Low Moderate No 
421 Ranstad et al.(2014) Low Moderate High High Moderate Moderate Moderate Low Moderate No 
422 Rast et al.(2014) Moderate Moderate High High Moderate High Moderate Unclear Moderate Yes 
423 Reinke et al.(2019) High Moderate High High Moderate High Moderate Low High No 
424 Ribeiro et al.(2018) High Moderate Moderate High Moderate High Moderate Unclear Moderate Yes 
425 Rose et al. (2018) Moderate Moderate Moderate High Moderate High Moderate Unclear Moderate Yes 
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426 Roso-Llorach et al.(2018) Low Moderate High High High Low Moderate Low High No 
427 Rozzini et al.(2002) High Moderate Moderate High Moderate High Moderate Unclear Moderate Yes 
428 Ruel et al.(2014) Moderate Moderate Moderate High Moderate High Moderate Unclear Moderate Yes 
429 Ruel et al.(2014) Moderate Moderate Moderate High Low High Moderate Low Moderate Yes 
430 Russell et al.(2020) Moderate Moderate Moderate High Low High Moderate Unclear Moderate Yes 
431 Ryan et al.(2018) Moderate Moderate Moderate High Moderate High Moderate Low Moderate Yes 
432 Sasseville et al.(2019) Low Moderate Moderate High Low High Low Low Low Yes 
433 Barnett et al. (2012) Low Moderate Moderate High Moderate Low Low Low Low Yes 
434 Schafer et al.(2014) Low Moderate Moderate High Low Low Moderate Low Low Yes 
435 Schafer et al.(2010) Low Moderate Moderate High Moderate Low Moderate Unclear Moderate Yes 
436 Schamess et al.(2017) High Moderate Moderate High Moderate Low Moderate Low Moderate No 
437 Schilling et al.(2013) High Moderate High High Low Low Moderate Unclear High No 
438 Schmidt et al.(2016) Low Moderate Moderate High Moderate High Moderate Unclear Moderate Yes 
439 Schneeweiss et al.(2001) Low Moderate Moderate High Moderate Low Moderate Unclear Moderate Yes 
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440 Schneeweiss et al.(2003) Low Moderate Moderate High Moderate Low Moderate Unclear Moderate Yes 
441 Schottker et al.(2016) Moderate Moderate Moderate High Moderate Moderate Moderate Low Moderate Yes 
442 Schuttner et al.(2020) Low Moderate Moderate High Moderate Low Moderate Low Moderate Yes 
443 Schuz et al.(2011) High Moderate Moderate High Moderate High Moderate Low Moderate Yes 
444 Schuz et al.(2015) High Moderate Moderate High Moderate High Moderate Unclear Moderate No 
445 Schuz et al.(2016) High Moderate Moderate High Moderate High High Unclear High No 
446 Schuz et al.(2014) High Moderate High High Moderate High Moderate Unclear High Yes 
447 Schuz et al.(2012) High Moderate High High Moderate High Moderate Unclear High Yes 
448 Selim et al.(2004) Moderate Moderate Moderate High Moderate High Moderate Unclear Moderate No 
449 Seo et al.(2017) Low Moderate Moderate High Low High Moderate Low Moderate No 
450 Seo et al.(2019) Low Moderate Moderate High Moderate Low Moderate Unclear Moderate Yes 
451 van den Bussche et al. 
(2011) 
Low Moderate Moderate High Moderate Low Moderate Low Moderate Yes 
452 Shakib et al.(2016) High Moderate Moderate High Moderate Low Moderate Unclear Moderate No 
453 She et al. (2019) Moderate Moderate Moderate High Moderate High Moderate Low Moderate Yes 
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454 Shih et al.(2015) Low Moderate High High Moderate Moderate Moderate Low Moderate Yes 
455 Shih et al.(2016) Low Moderate Moderate High Moderate Low Moderate Unclear Moderate Yes 
456 Shwartz et al.(1996) Moderate Moderate High High Moderate Low Moderate Unclear Moderate No 
457 Silay et al.(2017) High Moderate High High Moderate High Moderate Unclear High No 
458 Singer et al.(2019) Low Moderate Moderate High Moderate Low Moderate Unclear Moderate Yes 
459 Singh et al.(2019) Low Moderate Moderate High Low Low Moderate Unclear Moderate Yes 
460 Smith et al.(2008) High Moderate Moderate High High Low Moderate Low High No 
461 Spangenberg et al.(2011) Moderate Moderate High High Moderate High Moderate Unclear Moderate Yes 
462 St Sauver et al.(2015) Low Moderate Moderate High Moderate Low Moderate Low Moderate Yes 
463 Stanley et al.(2017) Low Moderate Moderate High Moderate Low Moderate Unclear Moderate No 
464 Stanley et al.(2018) Low Moderate High High Moderate Low Moderate Low Moderate Yes 
465 Starfield et al.(2003) Low Moderate High High Moderate Low Moderate Unclear Moderate No 
466 Steel  et al.(2019) Low Low Moderate High Low Low Low Low Low Yes 
467 Steinman et al.(2012) Low Moderate Moderate High Moderate Low Moderate Unclear Moderate No 
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468 Stenholm et al.(2015) Low Moderate High High Moderate High Moderate Low High No 
469 Stepanova et al.(2015) Low High High High High High High Unclear High Yes 
470 Stickley et al.(2020) Low Moderate High High Moderate High Moderate Low High Yes 
471 Stokes et al.(2017) Moderate Moderate Moderate High Moderate High Moderate Low Moderate Yes 
472 Streit et al.(2014) Moderate Moderate Moderate High High High Moderate Unclear Moderate Yes 
473 Strickland et al.(2018) Moderate Moderate High High Moderate High Moderate Low Moderate Yes 
474 Stubbs et al. (2018) Low Moderate High High Moderate Low Moderate Low Moderate Yes 
475 Stukenborg et al.(2001) High Moderate Moderate High High High Moderate Unclear High No 
476 Su et al.(2016) Moderate Moderate Moderate High Moderate High Moderate Low Moderate Yes 
477 Subramaniam et al.(2019) High Moderate Moderate High Moderate High Moderate Low Moderate No 
478 Sullivan et al.(2012) Low Moderate Low High Moderate Low Moderate Unclear Moderate No 
479 Sundararajan et al.(2004) Low Moderate Moderate High Low Low Moderate Unclear Moderate Yes 
480 Sundararajan et al.(2007) Low Moderate Moderate High Moderate Low Moderate Unclear Moderate Yes 
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481 Sundstrup et al.(2017) Low Moderate High High Moderate High Moderate Unclear High Yes 
482 Susser et al.(2008) High Moderate Moderate High Moderate High Moderate Unclear Moderate No 
483 Tai et al.(2006) Low Moderate Moderate High Moderate Low Moderate Unclear Moderate Yes 
484 Takahashi  et al.(2016) Moderate Moderate High High High Low Moderate Low High No 
485 Taleshan et al.(2018) Low Moderate Moderate High Moderate Low Moderate Low Moderate Yes 
486 Tan et al.(2013) High Moderate Moderate High Moderate Low Moderate Low Moderate Yes 
487 Tetzlaff et al.(2017) Low Moderate High High Moderate Low Moderate Low Moderate Yes 
488 Thavorn et al.(2017) Low Moderate Moderate High Low Low Moderate Low Low Yes 
489 Theou  et al.(2012) Moderate Moderate Moderate High Moderate Low Moderate Low Moderate No 
490 Thompson  et al.(2015) Low Moderate Moderate High Moderate Low Moderate Unclear Moderate Yes 
491 Thygesen  et al.(2011) Low Moderate Moderate High Moderate Low Moderate Low Moderate Yes 
492 Tinetti et al.(2011) Low Moderate High High High High Moderate Unclear High No 
493 Tinetti et al.(2012) Low Moderate High High Moderate Low Moderate Unclear Moderate No 
494 Tinetti  et al.(2015) Low Moderate Moderate High Moderate Low Moderate Low Moderate Yes 
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495 Tinetti  et al.(2019) High Moderate Moderate High Moderate High Moderate Low Moderate No 
496 Tooth et al.(2008) Low Moderate Moderate High Moderate Low Moderate Unclear Moderate Yes 
497 Troelstra et al.(2020) High Moderate High High Moderate Low Moderate Unclear High Yes 
498 Tyack et al.(2016) High Moderate Moderate High Moderate High Moderate Low Moderate No 
499 Tyack et al.(2018) High Moderate Moderate High Moderate High Moderate Unclear Moderate Yes 
500 Tyack et al.(2018) High Moderate High High Moderate Moderate Moderate Unclear Moderate Yes 
501 Umegaki et al.(2017) High Moderate Moderate High High High Moderate Low High No 
502 Valdivieso et al.(2018) Low Moderate Moderate High Moderate High Moderate Low Moderate No 
503 van den Brink et al.(2017) High Moderate Moderate High Moderate Low Moderate Low Moderate No 
504 van Walraven et al.(2009) Low Moderate Moderate High Moderate Low Moderate Unclear Moderate Yes 
505 van Zon et al.(2020) Moderate Moderate Moderate High Moderate High Moderate Unclear Moderate Yes 
506 Vancampfort et al.(2017) Low Moderate Moderate High Moderate Low Moderate Low Moderate Yes 
507 Vasilopoulos et al.(2014) Moderate Moderate Moderate High Low High Moderate Unclear Moderate Yes 
508 Vassilaki et al.(2015) Low Moderate Moderate High Moderate Low Moderate Unclear Moderate Yes 
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509 Vassilaki et al.(2016) Low Moderate Moderate High Moderate Low Moderate Unclear Moderate Yes 
510 Vetrano et al.(2016) Low Moderate Moderate High Moderate Moderate Moderate Low Moderate Yes 
511 Vila-Rodrigue et al.(2013) High Moderate Moderate High Moderate High Moderate Unclear Moderate No 
512 Villarreal et al.(2015) High Moderate Moderate High Moderate High Moderate Low Moderate No 
513 Violan et al. (2019) Low Moderate Moderate High High Low Moderate Low Moderate Yes 
514 Violan et al. (2014) Low Moderate Moderate High Moderate Low Moderate Low Moderate Yes 
515 Vitry et al.(2009) Moderate Moderate Moderate High Moderate Low Moderate Unclear Moderate Yes 
516 Volaklis et al.(2018) Moderate Moderate Moderate High Moderate High Moderate Low Moderate Yes 
517 von Strauss et al.(2000) Moderate Moderate Moderate High Moderate Low Moderate Low Moderate No 
518 Vos et al.(2013) Moderate Moderate High High Moderate High Moderate Low Moderate No 
519 Vu et al.(2019) High Moderate High High Moderate High Moderate Low High No 
520 Wagner et al.(2019) Low Moderate Moderate High Moderate Low Moderate Low Moderate No 
521 Wallace et al.(2016) Moderate Moderate Moderate High Moderate Low Moderate Low Moderate Yes 
522 Wang et al.(2009) Low Moderate Moderate High High Low Moderate Unclear Moderate No 
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523 Wang et al. (2018) Moderate Moderate Low High Moderate Low Moderate Unclear Moderate Yes 
524 Wang et al. (2017) Moderate Moderate Moderate High Moderate High Moderate Low Moderate Yes 
525 Wei et al. (2019) Low Moderate Low High High High High Low High No 
526 Wei et al. (2018) Low Moderate Moderate High Moderate High High Low High No 
527 Wei et al. (2016) Low Moderate Moderate High Moderate High High Unclear High No 
528 Wei et al. (2019) Low Moderate Moderate High Moderate High High Low High No 
529 Wei et al. (2018) Low Moderate Moderate High Moderate High High Low High No 
530 Wei et al. (2020) Moderate Moderate Moderate High Moderate High High Low Moderate No 
531 Welmer et al. (2012) Moderate Moderate Moderate High Low High High Unclear High No 
532 Whitson et al. (2016) Low Moderate Moderate High Moderate Low Moderate Unclear Moderate No 
533 Wijers et al. (2019) Low Moderate Moderate High Moderate High Moderate Low Moderate No 
534 Wikstrom et al. (2015) Low Moderate Moderate High Low Low Moderate Low Low Yes 
535 Williams et al. (2016) Moderate Moderate Moderate High Moderate High Moderate Unclear Moderate No 
536 Wister et al. (2015) Low Moderate Moderate High Moderate High Moderate Low Moderate Yes 
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537 Woldesemayat  et al. 
(2018) 
High Moderate Moderate High Moderate High Moderate Low Moderate Yes 
538 Wong et al. (2016) Low Moderate Moderate High Moderate Low Moderate Low Moderate Yes 
539 Yang et al. (2014) Moderate Moderate Moderate High Moderate High Moderate Low Moderate No 
540 Yao et al. (2020) Moderate Moderate Low High Moderate High Moderate Low Moderate Yes 
541 Yorke et al. (2017) Moderate Moderate Moderate High Moderate High Moderate Unclear Moderate Yes 
542 You et al. (2019) Moderate Moderate Moderate High Moderate High Moderate Low Moderate Yes 
543 Zekry et al. (2012) Moderate Moderate Moderate High Moderate Low High Unclear Moderate Yes 
544 Zekry et al. (2010) Moderate Moderate Moderate High Moderate Low Moderate Unclear Moderate Yes 
545 Zimmerman et al. (2017) Low Low Moderate High Moderate High Moderate Low Moderate No 
546 Zielinski  et al. (2011) Low Moderate High High Moderate Low Moderate Low Moderate No 
547 Zhang et al. (2020) Moderate Moderate Low High Moderate Low Moderate Low Moderate Yes 
548 Zhang et al. (1999) High Moderate High High Moderate Low Moderate Unclear High Yes 
549 Zulman et al. (2015) Low Moderate Moderate High Moderate Low Moderate Low Moderate No 
550 Zielinski et al. (2009) Low Moderate High High Moderate Low Moderate Low Moderate No 
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551 Miller et al. (1992) High High High High Moderate High Moderate Unclear High Yes 
552 van den Brink et al. (2020) High Moderate High High Moderate Low Moderate Low High No 
553 Khanam et al. (2011) Moderate Moderate Moderate High Moderate Low Moderate Unclear Moderate Yes 
554 Cornell et al. (2009) Low Moderate High High Moderate Low Moderate Unclear Moderate Yes 
555 Guerra et al. (2019) Moderate Moderate Moderate High Moderate High Moderate Low Moderate Yes 
556 Peng et al. (2020) Low Moderate Moderate High Moderate Low Moderate Low Moderate Yes 
557 Wang et al. (2020) Low Moderate High High Moderate High Moderate Low High Yes 
558 Canizares et al. (2018) Moderate Moderate Low High Moderate High Moderate Low Moderate Yes 
559 Cassell et al. (2018) Low Moderate High High Moderate Moderate Moderate Low Moderate No 
560 Wang et al. (2014) Low Moderate Low High Low Low Low Low Low Yes 
561 Wong et al. (2019) High Moderate Moderate High Moderate High Moderate Unclear Moderate Yes 
562 Chung et al. (2015) Low Moderate Moderate High Moderate Moderate Moderate Unclear Moderate Yes 
563 Nicholson et al. (2019) Low Moderate High High Moderate High Moderate Low High Yes 
564 George et al. (2006) High Moderate High High Moderate High Moderate Unclear High Yes 
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565 Von Korff et al. (1992) Low Moderate High High Moderate Low Moderate Unclear Moderate Yes 










Table S6: Overall risk of bias and transparent reporting of multimorbidity measurement 
 
Overall risk of bias* 
 
Transparent reporting of MM measure 
and definition 
Low Moderate High 
Yes (n=379) 36 (9%) 318 (84%) 25 (7%) 
No (n=187)  4 (2%) 101 (54%) 82 (44%) 
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